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INTRODUCTION 
Due to the difference in the major objective of the two investi-
gations reported herein, this dissertation has been divided into two 
parts. Each is complete and independent of the other and contains its 
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Biological membranes serve a number of important functions in all 
living organisms. In general, membranes function in (1) the regulation 
of the identity and rate at which materials are transported into or out 
of a cell or cellular organelle, (2) the recognition of cellular regu-
lators, (3) nerve impulse conduction, and (4) certain metabolic 
processes such as biosynthesis, electron transport, and photosynthe-
sis. 24 Although biological membranes have been the subjects of many 
investigations in recent years, much remains to be learned about the 
relationship between membrane structure and function. For example, 
how does membrane structure affect the selective transport of materials 
across a cell or organelle membrane? What role does membrane structure 
play in the biosynthesis of macromolecules such as cell wall polymers, 
glycoproteins, and DNA? Why is the presence of water and inorganic 
cations essential to the maintenance of membrane structure? A complete 
understanding of the answers to these questions and many others will 
come.only as a result of a more thorough knowledge of membrane structure. 
Biological Membranes 
Before examining the methods that can be used to study membrane 
structure, a discussion of the features of membrane structure that are 
3 
presently known is appropriate. The major components of all biologi-
cal membranes are lipids (ca. 40% dry weight), proteins (ca. 60% dry 
weight), carbohydrates (ca. 1-10% total dry weight), and water (ca. 
20% total weight). 24 Although a variety of different types of lipids 
can be found in membranes, the most common one is the phospholipid. 
The general structure for this lipid is shown (Figure 1). A phospho-
lipid consists of a polar "head" and two nonpolar "tails". The 
aliphatic chains comprising the phospholipid "tails" are of varying 


















m, n = 10-22 (14, 16 most common) 
R = cH2cH2NH3, CH2cH2N(CH3), CH2,Hco2H 
NH2 
Figure 1. General Structure of a Phospholipid. 
4 
A large number of structural models have been proposed to explain 
the manner in which the components of a membrane are associated with 
each other. Currently, the most widely accepted model of membrane 
structure is the Fluid Mosaic Model (Figure 2). 52 In this model the 
phospholipids are arranged in a bilayer with the hydrophilic "heads" 
(represented by the circles) on the outer surfaces and the hydrophobic 
"tails" (represented by the zigzag lines) on the inside. The membrane 
proteins are associated with the bilayer in two different ways. Most 
of the globular proteins are embedded in the lipid matrix and extend 
either partially or completely through the lipid bilayer. The remain-
der of the proteins (not shown in Figure 2) is associated strictly 
with the polar "heads" on the bilayer surface. Although supported by 
most experimental data, this model still does not adequately explain 
many of the membrane structure-function relationships. 
Figure 2. Fluid Mosaic Model. 52 
5 
Fluorescent Probes of Biological Membranes 
A variety of methods can be used to study membrane structure and 
its relationship to its various functions. Among the most common 
methods are freeze-fracture electron microscopy, 9 •60 X-ray diffrac-
tion,27 electron spin resonance (ESR), 32 nuclear magnetic resonance 
(NMR), 26 • 45 , 48 •35 and fluorescence spectroscopy. 5 ' 8 X-Ray diffraction 
6 
studies of phospholipid vesicles have been used to verify the existence 
of a lipid bilayer structure21 while freeze-fracture techniques have 
been used to examine the internal anatomy of biological membranes. 9 ' 60 
ESR has been used to study the mobility of a free-radical probe incor-
porated into an artificial or biological membrane and the polarity of 
its environment. NMR has been used to study not only the mobility of 
the lipids in the membrane but also the location of an incorporated 
probe and the amount of perturbation induced by its incorporation. 26 •45 
One of the most versatile and widely used techniques, however, 
involves the incorporation of a fluorescent probe such as ! or ~ into 
an artificia.l or biological membrane followed by an appropriate fluores-
cence experiment. Since this technique is so important in the study of 
membrane structure and function, it will be discussed in some detail 
beginning first with a short discussion of the fluorescence phenomenon 
itself. 
1 2 
In most molecules, the overall electronic energy state can be 
classified as either a singlet (S) or a triplet (T) state. 62 In the 
singlet state, the spins of all electrons in a molecule are paired, 
whereas in the triplet state the spins of one set of electrons are 
unpaired. At room temperature most molecules are in the ground state, 
s0 . Absorption of ultraviolet or visible light with a frequency, v, 
raises the molecules from the ground state to an excited singlet 
electronic state such as s1 or s2 (Figure 3). 62 The identity of the 
excited state depends upon the energy (E = hv) of the incident radi-
ation. Generally, the molecule quickly returns to the lowest excited 
7 
state, s1 , by transferring its excess energy to other molecules through 
collisions or by other nonradiative modes. The molecule can return to 
the ground state by a number of methods. First, the return to s0 may 
occur as a result of a nonradiative transition known as internal con-
version. Second, the molecule can return to the ground state through 
a radiative transition (s1 -+ s0) known as fluorescence. The frequency 
and energy of the emitted light are lower than those of the incident 
or exciting radiation. Thus, fluorescence occurs at a longer wave-
length than absorption. Third, the molecule can undergo intersystem 
crossing from the excited singlet state to the lowest triplet state 
(S1 -+ T1). The molecule can return to the ground state from the triplet 
state by a radiative process known as phosphorescence or by collisional 
deactivation. The efficiency with which fluorescence competes with the 
other electronic relaxation mechanisms is described by the fluorescence 
quantum yield, ~F· Thus, 
quanta emitted as fluorescence (1) 
quanta absorbed from incident light 
where ~ is the rate constant for fluorescence and kNR is the rate 
8 
constant for nonradiative decay from s1 . The rate constant, ~R' 




















Figure 3. Electronic Transitions Leading to Fluorescence 
and Other Relaxation Processes. Straight 
arrows denote nonradiative transitions. Wavy 




Fluorescent probes are small molecules (relative to the system 
being studied) that can provide information about the limited volumes 
in which they are located. 8 In general, probes can be classified as 
either intrinsic or extrinsic. Intrinsic probes are those such as 
8 
tryptophan that occur naturally in the system being studied. Extrinsic 
probes are those that are artificially incorporated into the system 
being studied. In order for an extrinsic probe to be useful, there are 
several criteria that it must meet, namely that (1) the probe must be 
9 
sensitive to the properties of the systems that are being studied; 
(2) the absorption spectrum of the probe should lie at lower frequency 
than the absorption spectra of any intrinsic probes commonly found in 
the system; (3) perturbation of the system resulting from incorpor-
ation of the probe should be minimal; (4) the location of the probe 
within the system should be known; and (5) the probe should be stable 
under the conditions used to study a given system. 
Fluorescence experiments using extrinsic probes have been useful 
in studying various aspects of membrane structure. Some of the 
properties of biological membranes that have been investigated using 
this technique are polarity, rotational mobility or microviscosity, 
d . t b 1 d b . 4,11,61 d is ances etween se ecte mem rane components or sites, an 
conformational changes in membrane structure. It is important to 
note, however, that this information on the biological system is 
obtained indirectly. These experiments provide direct information 
only about the probe itself. 
Many of the fluorescent probes used today are sensitive to the 
polarity of their immediate environments. In many cases, a change in 
the polarity of the surrounding medium results in a change in the 
wavelength of the emission maximum and the fluorescence quantum yield 
of the probe. For example, the probe~ l-anilinonaphthalene-8-sulphonate 
or ANS (~), shows a large increase in ¢F and a shift of its fluorescence 
maximum to shorter wavelength when transferred from a polar to a non-
. 24 
polar medium. The fluorescent chelate probe, chlorotetracycline (~), 
also shows a large dependence on the polarity of its surroundings. 
The fluorescence of chlorotetracycline complexed to a divalent cation 









Fluorescent probes have also been used to monitor changes that 
occur in membranes during various biological processes. Caswell and 
2+ 
Warren used chlorotetracycline (~) to monitor ATP-induced Ca uptake 
and binding in skeletal and cardiac muscle microsomes. 17 Jasaitis and 
10 
co-workers studied changes in ANS fluorescence induced by a membrane 
potential in mitochondria and submitochondrial particles. 28 They found 
that ANS fluorescence decreased as the membrane interior became more 
negative and increased as it became more positive. Schuldiner and 
co-workers have used a variety of probes, ~ through 2• to continuously 
. 51 
monitor the changes in ~pH in chloroplasts. 
A large number of different probes have been used to determine the 
gel-liquid crystalline transition temperature of various artificial and 
biological membranes. bansylphosphatidylethanolamine (.!.Q), 9-methyl-
anthracene (11), and ANS were used to study order-disorder transitions 
of the aliphatic chains of phospholipids in bilayer systems. The 
probes 10 and 11 gave the expected transition temperatures for dimyris-
toylphosphatidylcholine and dipalmitoylphosphatidylcholine bilayers. 
In contrast ANS showed no phase transition presumably due to its 
location in the polar region of the lipid bilayer. The probe, N-phenyl-
1-naphthylamine (12), was used to detect phase transitions in cells, 
membranes, and lipids of Escherichia coli. 44 At concentrations less 
-5 than 10 M, the probe did not affect the transition temperature. At 
-5 -4 
concentrations between 10 and 5 x 10 M, the transition temperature 
1 d b 3o-7oc. was owere· y This suggested that the probe penetrated the 
11 
nonpolar region of the membrane and interfered with the orderly packing 
of the lipid chains at higher concentrations. 





10 11 12 
Several different research groups have used (9-anthroyl)-substi-
tuted fatty acids to detect phase transitions of lipid bilayers. 
42 
Radda and co-workers used 12-(9-anthroyl)stearic acid (12-AS) (13) 
to study the gel-liquid crystalline transition of an oriented lipid 
bilayer. Using photobleaching experiments, they concluded that 12-AS 
was excluded from the lipid matrix and formed regions of localized 
high concentration below the transition temperature, T . Cadenhead 
c 
and co-workers 13 used 2-(9-anthroyl)palmitic acid (2-AP) (14), 12-AS, 
and 16-(9-anthroyl)palmitic acid (16-AP) (15) to determine the main 
phase transition temperature of dipalmitoylphosphatidylcholine (DPPC) 
bilayers. 0 Using 2-AP, T was found to be 39 C; 12-AS gave a value of 
c 
40°c while 16-AP gave a value of 41.5°c. These values were lower than 
the value of 41.5-42.S 0 c determined by differential scanning calori-
59 
metry. In similar studies by Thulborn and Sawyer, however, 2-AP, 
6-(9-anthroyl)stearic acid (6-AS) (16), 9-(9-anthroyl)stearic acid 
(9-AS) (17), and 12-AS all gave a transition temperature of 41.6°c 
for DPPC bilayers. 
13 m= 5 ' n=lO 
14 m=l3, n= 0 
16 m=ll, n= 4 
15 
17 m= 8 ' n= 7 
12 
Fluorescent probes have also been used to study interactions of 
11 various membrane components. For example, Radda and co-workers have 
calculated the average distance between incorporated ANS probes and 
the tryptophan moieties of proteins present in erythrocyte ghosts and 
0 
submitochondrial particles to be 20-25 A. These distances were deter-
mined using fluorescence donor-acceptor measurements. Stoffel and 
Michaelis54 •55 have synthesized and examined a variety of phospha-
tidylcholines in which the second position contains a (9-anthryl)-
substituted fatty acid moiety. These probes 18, !_2, and 20 were used 
13 
to study lipid-lipid and lipid-protein interactions in liposomes (DPPC) 
and phospholipid extracts of an 1'._. coli mutant. 
CH 3 <CH 2 ) 4 CH==CHCH 2CH==CH(CH 2 ) 7C0 2CH 2 
~CH2CH~CHCCH 2 l 4 C0 2CH 
18 
+ 
CH 20P0 3CH 2CH 2N<CH 3 ) 3 
CH 3 <CH 2 ) 4 CH=CHCH 2CH:::CH<CH 2 ) 7C0 2CH 2 




CH 20P0 3 CH 2 CH 2 N<CH 3 ) 3 
Recently, the synthesis and fluorescence studies of 1,2-bis[w-(l-
pyreno)decanoyl]-sn-glycero-3-phosphorylcholine (DPPL) (21), 58 ethyl 
58 
w-(1-pyreno)decanoate (EP) (~), and a trans-stilbene-substituted 
fatty acid (23) 49 have been reported. In addition, rose bengal (24) 
has been used to study the extent of exposure of the hydrocarbon 
h . . . 11 49 c ains in aqueous mice es. Another recent investigation involved 
saturation studies of the fluorescent probes, 2-AP, 2-AS, 12-AS, and 
16-AP. 43 Najjar found that these probes reached a critical concen-
tration in lipid vesicles. Above this concentration the probe was 
found in two different environments, presumably the nonpolar environ-
ment of the bilayer and the more polar environment of the buffer 









Although many fluorescent probes are available either commercially 
or through synthetic pathways reported in the literature, many of these 
probes do not meet all of the criteria set forth previously. For 
example, the location of probes such as 1,6-diphenylhexatriene (l) and 
9~methylanthracene (11) within the lipid bilayer is uncertain. 54 In 
order for the results of fluorescence experiments to be interpreted 
validly, the location of the probes used must be known. Other probes 
such as 14, 16, 18, and 21, which contain a pyrene, 9-anthryl, or 9-
anthroyl moiety, are believed to perturb the environments being studied 
13 
to some extent. The 9-anthroyl moiety of 12-AS (13) has been reported 
to undergo cleavage from the probe during attempts to incorporate it 
. b" 1 . 1 55 into a 10 og1ca system. 
The synthesis of a new class of fluorescent probes, the w-(2-
3 anthryl)substituted fatty esters (25), has been recorded recently. 
It is believed that these probes will of fer several advantages over 
those currently available, namely that (1) the probes will occupy a 
known location within the bilayer depending upon the length of the 
fatty acid or ester, (2) the probe will be stable under biological 
conditions, and (3) the probe should cause less perturbation to the 
lipid bilayer than those containing a 9-anthryl or 9-anthroyl moiety. 
Ideally, however, the length of the fatty acid to which the 2-anthryl 
group is.attached should mimic those found in natural membranes. 
Thus, the ideal fluorescent probe for biological membranes may well 
be those such as 25 in which n = 11 - 17. 
25a n= 2, R=C 2H5 
25b n= 4. R=CH 
3 
25c n= 6, R=CH 
3 
25d n=ll, R=CH 
3 
25e n=l3, R=CH 
3 
25f n=l6, R=CH 
3 
Carbon-13 Spin Lattice Relaxation Times 
Although structural and stereochemical assignments for solid 
organic compounds are readily made using single crystal X-ray 
diffraction studies, similar determinations for these same compounds 
in solution or for liquid organic compounds are not as easily accom-
plished. The most common tools employed in the latter cases include 
1H and 13c N)'lR chemical shifts and spin-spin coupling constants for . 
these and other NMR active nuclei. The most recent and perhaps most 
useful method for these determinations, however, involves the use of 
13c · 1 · 1 · · spin- attice re axation times. Unlike the NMR chemical shift and 
spin-spin coupling data, the relaxation times obtained from these 
experiments can be used to determine not only molecular structure but 
37 
also molecular motion and local and overall molecular geometry. 
This section will provide a non-mathematical discussion of the spin-
lattice relaxation phenomenon and its use in the determination of 
molecular structure and motion. 
16 
A · 1 13 NMR · b h d typica C experiment, including ot excitation an 
relaxation processes, can be described most easily using the "rotating 
frame of reference" (Figure 4). 46 In this model, the entire coordi-
nate system rotates at the resonance frequency, w • 
0 
The external 
magnetic field, H , is applied along the z axis while the rf field is 
0 
applied along the x axis. When 13c nuclei are placed in a magnetic 
field, the spin of each nucleus becomes aligned with or against the 
applied field. At equilibrium, the distribution of the spins is such 
that the lower energy level is slightly more populated than the upper 
energy level resulting in a net equilibrium magnetization, M (Figure 
0 
4a). When the sample is excited with rf radiation, the equilibrium 
distribution of the nuclear spins is perturbed. In terms of the 
rotating frame of reference, the magnetic component of the rf field 
rotates M out of alignment with the applied field and toward the y 
axis. The extent of this rotation is dependent upon the pulse width 
of the rf radiation. Two pulse widths, which may be determined 
experimentally, are connnonly used - one which results in a tipping 
of M by 90° (90° pulse) and one in which M is completely inverted 
0 (180 pulse). 
Immediately after each excitation pulse, the process of spin-
lattice relaxation begins. This process, which involves the transfer 
of the energy absorbed by each nucleus to its surroundings or lattice, 
corresponds to relaxation along the z axis of the rotating frame of 
reference (Figure lb to le). In order for this energy transfer to be 
most efficient, some mechanism that couples the nuclear spins and the 
lattice is required. In general, four relaxation mechanisms, all of 
















































Figure 4. The ~otating Frame of Reference. 
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. 1 10 40 
fluctuating local fields, are commonly considered. ' ' These 
mechanisms, which include dipole-dipole relaxation, spin-rotation 
relaxation, chemical shift anisotropy relaxation, and scalar coupling 
relaxation, may contribute in varying amounts to the relaxation of a 
13 
given C nucleus. The first two mechanisms, however, are the most 
13 
common ones observed in C systems. 
Dipole-dipole (DD) relaxation, the most common relaxation mechanism 
13 13 
for C systems, is the result of interactions between a C nucleus and 
neighboring magnetic nuclei or unpaired electrons. If two magnetic 
nuclei such as 13c and 1H are bound to each other, then each nucleus 
feels not only the external applied field but also the local field 
generated by the nucleus to which it is attached. Since rotations of 
13 1 
C- H bonds are very fast in solution, the orientation of the two 
magnetic nuclei relative to the applied field will change continually. 
This continual reorientation of the two nuclear spins generates flue-
tuating local fields at each nucleus which contributes to the relax-
ation of the 13c nucleus. The rate of dipole-dipole, spin-lattice 
13 
relaxation for a C nucleus in a rigid,' isotropically tumbling 
molecule is given by: 
where RlDD is the DD, spin-lattice relaxation rate, TlDD is the DD, 
spin-lattice relaxation time, N is the number of directly bound 
hydrogens, Ye and yH are magnetogyric ratios for 13 c and 1H, respec-
(2) 
tively, rC-H is the C-H internuclear distance, and TC is the molecular 
1 . . 40 corre ation time. 
A second relaxation mechanism that is relatively common in 13c 
20 
systems is spin rotation (SR) relaxation. In SR, small molecules or 
freely rotating molecular segments can be relaxed effectively by the 
fluctuation of local fields generated by the rotation of the magnetic 
vectors of the bonding electrons involved. In these cases, SR 
relaxation often competes with DD relaxation for protonated carbons 
and dominates the relaxation of nonprotonated carbons. For example, 
C(l) of toluene is relaxed primarily by spin rotation. 38 The rate of 
13 
spin rotation, spin-lattice relaxation for a C nucleus in a spherical 
molecule is given by: 
1 2 TI k T C2 
2 I TSR \{ m 
where RlSR is the SR, spin-lattice relaxation rate, TlSR is the SR, 
spin-lattice relaxation time, k is Boltzmann's constant, T is the 
temperature in °K, Im is the moment of inertia, C is the isotropic 
SR . . d . h s 1 . . 40 interaction constant, an TlSR is t e R corre ation time. 
A third, less connnon relaxation mechanism is chemical shift 
(3) 
anisotropy (CSA) relaxation. In this mechanism a nucleus in a molecule 
tumbling in solution may be relaxed by fluctuating magnetic fields 
arising from anisotropy or directionality in the shielding of that 
nucleus. The rate of CSA, spin-lattice relaxation for a nucleus in 
a molecule of cylindrical symmetry is given by: 
(4) 
where RlCSA is the CAS, spin-lattice relaxation rate, TlCSA is the CSA, 
spin-lattice relaxation time, H is the applied magnetic field, and 
0 
cr 11 and crl. are the values of the shielding tensor parallel and perpen-
21 
40 
dicular to the symmetry axis, respectively. In general, the CSA 
relaxation mechanism is significant for 13c nuclei only at very high 
magnetic field strengths and in systems containing TI bonds. 
13 
The final relaxation mechanism found in C systems is scalar 
1 . (SC) 1 . T 1 ' 13 d h b d d coup ing re axation. wo nuc ei, C an X, t at are on e to 
each other may undergo spin-spin coupling if the lifetime of their 
respective nuclear magnetic energy levels is sufficiently large. If, 
however, one nucleus, X, relaxes much faster than the other, no 
splitting is observed. The fast relaxation of X may, however, generate 
fluctuating local magnetic fields at the 13c nucleus resulting in re-
13 
laxation of the C nucleus. The rate of SC, spin-lattice relaxation 
is given by: 
8 TI2 J2 





where RlSC is the rate of SC, spin-lattice relaxation, TlSC is the SC, 
spin-lattice relaxation time, J is the scalar coupling constant, S is 
the spin quantum number of X, wX and we ,are the Larmor frequencies of 
13 
X and C, and 'sc is the scalar coupling relaxation correlation 
time. 40 In general, the SC, spin-lattice relaxation mechanism is quite 
uncommon in 
13 
C systems and is important primarily in systems where 
13 79 36 
C is bonded to one or more Br atoms. 
Since a variety of relaxation mechanisms may contribute to the 
relaxation of a particular 13c nucleus, the overall relaxation rate 
may be considered to be the sum of the individual rates for each 
mechanism, that is, 
R 
lobsv 
R +R +R +R +R 






_l_ + _l_ + 1 + _l_ + 1 
RlDD TlSR TlCSA TlSC Tlother 
(7) 
In some instances the contribution of each mechanism to the relaxation 
of the nucleus may be determined. Dipole-dipole relaxation may be 
detected through its temperature dependence. As the temperature of a 
solution is increased, the overall T1 for a particular nucleus relaxing 
primarily by the DD mechanism also increases. The amount of DD relax-
ation for a 13c nucleus may be calculated from its nuclear Overhauser 
enhancement (NOE): 
% DD Relaxation = n x 100 (8) 
1. 988 
13 
where n is the NOE for a given C nucleus and the value of 1.988 is 
the maximum theoretical value for the 13c NOE. 37 
Relaxation primarily by spin rotation, chemical shift anisotropy, 
or scalar coupling may also be detected although the exact contribution 
of each mechanism is much more difficult to determine. In the case of 
a nucleus relaxing primarily by the SR mechanism, the observed T1 
decreases with increasing temperature. In contrast to this, predomi-
2 
nance of the CSA mechanism may be detected by its dependence on H . 
0 
Scalar coupling relaxation may also show a field dependence but not 
. h . 1 10 in sue a simp e manner. 
Although a variety of mechanisms may contribute to the overall 
13 
relaxation of a nucleus, in many C systems dipole-dipole relaxation 
is either the major or exclusive mechanism operating. Since the 
efficiency of DD interactions depends upon the rate of molecular 
reorientation, TlDD may be used to evaluate the overall and local 
13 
molecular motion in many C systems. A variety of equations that 
describe specific molecular motions are available. In many cases, 
however, complex mathematical manipulations are not required in 
order to obtain significant information concerning molecular dynamics 
2 19 
from T1 values. ' 
13 . 
Thus, the relationships between C T1 values 
and molecular motion form the basis for many applications in organic 
chemistry. 
One common application of 13c T values involves the determin-
1 
ation of structures of organic molecules. T1 values may be used to 
37 
distinguish between protonated and nonprotonated carbons. In some 
13 
cases, C T1 values can also distinguish between the various non-
23 
protonated carbons based on the number of protons attached to adjacent 
1 -6 
carbons (~~~ r ). For example, C(l), C(3,5), and C(4) of mesca-
TlDD C-H 




two ortho protons shows the smallest T1 while C(3) and C(S), each with 
one ortho proton, shows a longer T1 and C(4) with no ortho protons shows 
the longest T1 of the three different nonprotonated carbons. 
A second application of 13c T1 values involves the determination 
10 37 
of preferred or anisotropic tumbling of a molecule. ' As a result 
of many different electrical, chemical, and physical effects, many 
small, compact molecules tumble anisotropically in solution. For 
example, rotation about the c2 molecular synnnetry axis is highly 
favored in monosubstituted benzenes (Figure 5). This leads to modu-
lation of the dipole-dipole interactions of the ortho and meta 
carbons and their respective protons but not the para carbon and its 
proton. 
38 
Thus, for monosubstituted benzenes, such as 27, that 
tumble anisotropically about the c2 axis, the T1 value for the para 
carbon should be shorter than those for the ortho and meta carbons. 
This behavior may be used to assign similar resonances from more 
complex molecules such as 3-bromobiphenyl (28) 37 and 3-methyl-5,6,7,8-






A third application of C T1 values involves the study of 
. 10 37 
molecular flexibility or segmental motion. ' In general, the 
carbons toward each end of a long chain hydrocarbon are more mobile 
24 
25 
than those in the middle of the chain. This difference in the mobility 
of various chain segments in the molecule results in minimum values for 
T1 for carbons at the center of the chain and maximum values at the 
ends. One example of this behavior is decane (30). 7 The larger T1 
values at the end of the chain and the smaller ones in the middle 
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4.36 5.71 8.74 
4.95 6 • 6 1 
H 
x - - - - c2 Axis 
in Monosubstituted Benzenes. 
Related to this change in segmental motion in various portions of 
the molecule is the change in molecular flexibility as a result of 
hydrophobic or hydrophilic interactions and hydrogen bonding. In 
13 
1-decanol (31), for example, the C T1 values increase as the distance 
from the hydroxyl group increases. 18 Thus, the hydrocarbon end of the 
chain has more motional freedom than does the hydroxyl end. This 
behavior can be attributed to intermolecular hydrogen bonding between 
the hydroxyl groups. This restricts the mobility of the hydroxyl end 
of the molecule while leaving the hydrocarbon end free to move. In 
addition to 1-decanol, other alcohols such as the amino alcohols 39 
show similar effects. 
2. 2 1. 1 0.84 0.77 0.65 
3. 1 1. 6 1. 1 0.84 0. 7 7 
sec 
31 
The presence of hydrophobic or hydrophilic interactions can also 
b d d b . . 13c T 1 e etecte y monitoring 1 va ues. Many compounds, such as 
fatty acids, form inverted micelles when dissolved in a nonpolar 
solvent such as CHC13 • The formation of an inverted micelle may be 
detected through the larger T1 values for carbons at the nonpolar 
end of the molecule. In octanoic acid (32), 29 for example, T1 values 
increase steadily from the polar to nonpolar end of the molecule. 
This indicates greater mobility at the nonpolar end of the molecule 
and highly restricted motion at the polar end, both of which are 
indicative of the formation of an inverted micelle. 
Finally, some of the most recent applications of 13c T1 values 
involve the study of biological membranes. Johns and co-workers are 
currently involved in a series of studies concerning the nature of 
26 
13 29 30 
chloroplast membranes using C T values. ' Berlin and co-workers 
1 
11 1 h h 1 . 13 as we as severa ot er researc ers are current y using C T1 mea-
surements to examine the properties of a series of fluorescent probes 
for biological membranes. 3 , 31 
5.0 3. 1 2.3 
5 . 3 4 • 1 2.6 1. 9 
sec 
32 
In conclusion, the development of more sophisticated Fourier 
transform NMR instrumentation in the past ten years has led to 
increased interest in the use of 13c spin lattice relaxation measure-
ments. Although many theoretical questions remain to be answered at 
this time, these measurements off er a unique opportunity to obtain 




RESULTS AND DISCUSSION 
In order for a fluorescent probe to be useful in studies of 
biological membranes, it must meet several important criteria, namely 
that (1) the absorption spectrum of the probe should lie to the red 
(lower energy) of the absorption spectrum of tryptophan (A = 22024 
max 
nm), (2) the location of the probe within the membrane should be 
known, (3) perturbation resulting from the incorporation of the probe 
should be minimal, and (4) the probe should be stable under biological 
conditions. One of the newest classes of fluorescent probes that 
should meet these criteria is the w-(2-anthryl)substituted fatty 
ester 25. The syntheses of three members (~-25c) of this class of 
3 
probes have been published recently. Reported herein are the syntheses 
and NMR spectral analyses of three new fluorescent probes of this same 
class in which n = 11, 13, and 16 (~, 25e, and 25f). 
25a n=2, R=C 2H5 25d n=ll, R=CH 3 
25b n=4, R=CH 25e n=l3, R=CH 3 3 
25c n=6, R=CH 3 
25f n=l6, R=CH 3 
28 
The synthetic approach designed to prepare the probes 25d-~ 
(Figure 6) involved a Wittig reaction using phosphonium salt 33 and 
an appropriate oxo-ester ~-34c to give the unsaturated esters 35a, 
35b, and 35c in good to excellent yields (77%, 90%, and 81%, respec-
tively). Hydrogenation of 35a-35c in ethyl acetate at atmospheric 
pressure using 10% Pd/C as a catalyst gave the desired saturated 
esters 25d, 25e, and 25f in good yields (75%, 80%, and 80%, respec-
tively). Each of these esters was purified rigorously by two recrys-
tallizations from 95% ethanol followed by two molecular distillations 
using a sublimation apparatus. The slightly impure esters were pale 
yellow solids, whereas, the highly purified compounds were white 
powders. 
The synthesis of the phosphonium salt 33 from the commercially 
available 2-methylanthraquinone (36) was achieved in several steps. 
. bl. h d d 6,14,22,25,53 2 h 1 h Using pu is e proce ures, -met y ant raquinone was 
converted to 2-hydroxymethylanthracene (37) in an overall yield of 
45%. Treatment of 37 with triphenylphosphine dibromide in DMF at room 
temperature gave the corresponding bromide 38 in an 84% yield. As 
0 
CH 3 ~H20H ~H2BR 
37 38 
indicated by melting points, 2-bromomethylanthracene prepared by this 
method was of greater purity than that obtained by bromination of 
29 
2 ... d 34 -methylanthracene using N-bromosucc1n1m1 e. The desired phosphonium 
salt 33 was obtained through the treatment of 2-bromomethylanthracene 
with triphenylphosphine in boiling benzene. The phosphonium salt 33 
33 
(1) NaH/DMSO 




©IQ:©- CH =CH C CH2 l m CO 2 CH 3 
35a m=9, 77% 
]~~ m=ll, 90% 
l-2£ m=l4, 81% 
H2 , Pd/C 
CH 3co 2c 2H5 
RT, 1 atm 
4 h 
25d n=ll, 75% 
i~~ n=l3, 80% 
~2.f n=l6, 80% 
Figure 6. Synthesis of 25d-25f --
30 
was somewhat hygroscopic and had to be dried under vacuum over boiling 
ethanol prior to use. 
The w-oxoesters 34a-34c required for the synthesis of ~-25f are 
not available connuercially. The methods designed to prepare these 
compounds are shown in Figure 7. The oxoester ~was prepared from 
11-bromoundecanoic acid (39). Esterification of the acid 39 followed 
31 
by treatment with pyridine-_!!-oxide and NaHC03 in boiling toluene gave 
the desired oxoester in a modest overall yield (30%-50%). The oxoester 
34b was obtained via alkylation of 2, 4, 4-trimethyloxaz.oline using the 
lithium salt of 11-bromoundecanol at -78°c. Methanolysis of the 
resulting alkylated oxazoline ~ gave the w-hydroxyester 42 in a modest 
overall yield (47%). Oxidation using Cro3/pyridine gave the desired 
w-oxoester 34b (crude yield of 96%). This oxoester was sufficiently 
pure to be used in the Wittig reaction without further purification. 
The final oxoester 34c was prepared by methanolysis of dihydroambretto-
lide (43) to give the corresponding w-hydroxyester 44 (85%) which was 
oxidized to 34c-(84%) using CrO/pyridine. 
The synthetic approach used to prepare 25d-25f is similar to that 
used to obtain the shorter chain homologs 25a-25c in which n = 2, 4, 
and 6 (Figure 8). 3 Both methods involved the use of a Wittig reaction 
to attach the appropriate side chain to the anthracene moiety. Whereas 
the synthesis of ~-25f included Wittig reactions using an anthra-
cene-containing phosphonium salt and an appropriate oxoester, the 
syntheses of the shorter homologs ~-~ employed reactions of phos-
phoranes ~-45c with 2-anthraldehyde (46). Hydrogenation of the 
resulting unsaturated esters in ethanol at atmospheric pressure using 
10% Pd/C as a catalyst reduced not only the double bonds present in 
+:~CH3 








!::., 24 h 
(1) nBuLi/THF/-78°C 
(2) Br(CH2) llO-Li. 
-78°C/10 min 
RT /90 min 
Cr03/pyridine 
CH2Cl 2 
RT, 20 min 
!::., 18 h 
BR(CH 2 l 10 C0 2 CH 3 
40 
l pyridine-N-oxide NaHco3 · c6H5cH3 
!::., 6 h 
34a 
[ +>-(~:,l,,OH] 
l'"'"' H2 so4 !::., 18 h 
HO<CH 2 l 12 C0 2 CH 3 
42 
HO<CH 2 l 15 C0 2 CH 3 
44 
l Cro3/pyridine CH 2c1 2 
RT, 20 min 





45a n=O, R=c 2H5 
45b n=l, R=CHJ 



















25a n=2, R=C 2H5 
_?_;i]? n=4, R=CH 3 
25c n=6, R=CH 3 
Figure 8. Synthesis of 25a-25c. 
33 
the side chain but also the 9,10-positions of the anthracene ring. 
Subsequent aromatization using o-chloranil gave the desired 2-
anthryl-substituted fatty esters 25a, 25b, and 25c. 
3 The method used to prepare the shorter chain homologs 25a-25c 
34 
has several disadvantages in comparison to that used to obtain 25d-25f. 
First, 2-anthraldehyde (46) is a highly insoluble, light sensitive, 
and relatively unstable compound. Second, the phosphonium salts used 
to obtain the phosphoranes ~ and 45c are difficult to obtain in pure 
form. Third, the Wittig reactions used to obtain the unsaturated 
esters 47b and Lf le in which n = 2 and 3 proceed in modest to poor yields 
(36% and 19.7%, respectively). Fourth, a side reaction, reduction of 
the 9,10-positions of the anthracene ring, occurred under the conditions 
used. Finally, the Wittig reactions involving phosphoranes, such as 
45b and ~' cannot be applied readily to the preparation of longer 
chain homologs because the corresponding starting materials are not 
readily available either commercially or through published procedures. 
In contrast to this, the route developed for the synthesis of 
25d-~ has several advantages. First, the phosphonium salt 33 is 
quite stable (although hygroscopic) and can be stored for relatively 
long periods of time. Second, the Wittig reactions used to obtain the 
unsaturated esters 35a-35c proceed in good to excellent yields. Third, 
the hydrogenation of the unsaturated esters 35a-35c under the conditions 
used reduces only the carbon-carbon double bond present in the side 
chain and not the 9,10-positions of the anthracene ring. Finally, the 
Wittig reaction using the phosphonium salt 33 can be utilized to 
prepare the unsaturated esters with any chain length (assuming that 
the appropriate oxoester can be obtained). 
Initially, reduction of the 9,10-positions of the anthracene 
ring was expected in the conversion of the unsaturated esters 35a-35c 
3 to the corresponding saturated esters 25d-25f due to previous work. 
Under the conditions employed, however, only the carbon-carbon double 
bonds present in the side chain were reduced. Two factors may account 
for the reduction of the 9,10-positions in 47a-47c but not in 35a-35c. 
First, esters 47a-47c contain a highly conjugated side chain which 
may increase the reactivity of the 9,10-positions of the anthracene 
ring. Second, the hydrogenation of the esters 47a-47c was performed 
using the protic solvent ethanol, whereas, reduction of 35a-35c was 
performed using the aprotic solvent, ethyl acetate. 
The 1H NMR spectral assignments (100 MHz) for 25d-25f are shown 
in the Experimental Section. In all three esters, the methoxy protons 
appeared as a singlet at 8 3.64, 3.63, and 3.65, respectively. The 
protons alpha to the carbonyl, H(2), appeared as triplets centered 
at 8 2.28, 2.27, and 2.29, respectively. The protons alpha to the 
anthracene ring .[H(l2), H(14), and H(l 7), respectively] appeared as 
triplets centered at 8 2.78, 2.78, and 2.79. The remaining methylene 
protons of 25d-~ gave multiplets between 8 1.2-1.9, 1.2-1.7, and 
1.2-1.85. 
1 An H NMR spectrum performed using a Varian XL-300 NMR 
distinguished H(3) and H(ll) of 25d. In this spectrum, H(3) appeared 
as a multiplet at 8 1.48-1.62 while H(ll) appeared as a multiplet at 
8 1.62-1.74. 
Since later experiments required unequivocal assignment of H(2), 
H(3), H(ll), and H(12) of ~5d, isotope incorporation and selective 
homonuclear decoupling experiments were performed. The assignments 
35 
for H(2) and H(12) were distinguished by the incorporation of deuterium 
into 25d. The ester 25d was treated with NaOCH3 in CH30D at reflux 
for one hour. Quenching with D20, filtration, and recrystallization 
from c2H50D gave the ester 51 in which the protons on C(2) had been 
partially replaced by deuterium. The 1H NMR spectrum for ester 51 
showed a decreased intensity for the triplet at 8 2.28. A compari-
son of the integration for the signals at 8 2.78 and 2.28 indicated 
a ratio of 2:1.5 for the labeled ester, whereas in 26d the ratio 
was 2:2. Since the deuterium could only have been incorporated at 
C(2), this experiment permitted the assignment of the triplet at 
o 2.28 to H(2). The triplet at o 2.78 was, therefore, assigned to 
H(l2). The assignments for H(3) and H(ll) of 25d were made using . ~
homonuclear decoupling techniques. Irradiation of the triplet at 
o 2.28 resulted in the collapse of the multiplet at o 1.48-1.62 to 
a triplet. Therefore, the protons, H(3), must correspond to the 
multiplet at o 1.48-1.62. Irradiation of the triplet at o 2.78 
resulted in the collapse of the multiplet at o 1.62-1.74 to a 
triplet. Theref.ore, this multiplet at o 1.62-1. 74 must correspond 
to H(ll). 




The assignments for the aromatic protons in ~-~ cannot be made 
unequivocally except possibly through very complex labeling and selec-
tive decoupling experiments. Tentative assignments for 1H signals 
for the aromatic protons are shown in the Experimental Section. The 
manner in which these assignments were made will be discussed later 
· · · h h 13c · f h · b in connection wit t e assignments or t e aromatic car ons. 
The 13c NMR assignments and spin-lattice relaxation times (T1 
values) for the carbons in the side chain of 25d-25f are shown in 
Table I. The assignments for carbons 1', 1, 2, 3, and those a and 
S to the anthracene ring in 25d were made initially using model 
compounds (Table II). 50 •57 The assignments for these carbons, with 
the exception of C(ll) (S to the ring), agree quite closely with 
those for the ?ppropriate models. 
13 
Since the C NMR spectral assignments for the shorter chain 
homologs 25d and 25c had been published previously, a comparison 
of those assignments with the ones made initially for 25d using 
model compounds was made (Table III). Although one would expect 
slight shift differences (especially for the esters such as 25a 
with very short side chains), in general, analogous carbons within 
these compounds should have similar chemical shifts. The assignments 
for carbons 1', .1, and 3 in 25b, 25c, and 25d agreed quite closely. 
The assignments for carbons 2, a, and S differed drastically. Since 
these esters are very similar, it was expected that the signals at 
36.2 (25d), 36.0 (~), and 35.8 ppm (25b) should be assigned to 
analogous carbons. Similarly, the group of signals at 34.1 (25d), 
33.9 (25c), and 33.8 ppm (25b) and the group at 30.9 (25d), 30.6 
(25c), and 30.2 ppm (25d) should each be as~igned to analogous 
carbons. 
Because of the discrepancy in the assignments for carbons 2, a, 
and S in 25b, 25c, and 25d, two selective heteronuclear decoupling 
























13c NMR CHEMICAL SHIFTS (T1 VALUES (SEC)) FOR THE CARBONS IN 
THE SIDE CHAIN OF 25d-25f 
25d m= 9 -25e m=ll -25f m=l3 
Chemical Shifta (T1 Value (sec)) 
25d 25e 25f 
174.0 (44.5) 173.9 ( 45. 3) 174.0 (44.1) 
34.1 ( 1.96) 34.0 ( 1.92) 34.0 ( 2. 07) 
24.9 ( 1. 61) 24.9 ( 1.56) 24.9 ( 1. 83) 
29.1 ( 1.27) 29.1 ( 1. 31) 29.1 ( 1.42) 
29.2 ( 1.18) 29.2 ( 1.14) 29.2 ( 1. 25) 
29.4 ( 1.12) 29 .4 ( 0. 9 8) 29.4 ( 1.09) 
29.5 ( 0. 96) 29.5 ( o. 90) 29.6 ( 0.96) 
29.5 ( 0.96) 29.5 ( 0.90) 29.6 ( 0.96) 
29.5 ( 0. 96) 29 .5 ( 0.90) 29 .6 ( 0.96) 
29.3 ( 0.93) 29.5 ( 0.90) 29.6 ( 0.96) 
30.9 ( 0.85) 29.5 ( 0.90) 29.6 ( 0.96) 
36.2 ( 0.78) 29.3 ( 0. 79) 29.6 ( 0. 96) 
30.9 ( 0. 78) 29. 6 ( o. 96) 
36.2 ( 0.69) 29.6 ( 0.96) 
29.36 (0.92) 
31.0 ( 0.89) 
36. 2 ( 0. 80) 
51. 3 ( 6. 3) 51.2 ( 5.9) 51. 3 ( 6. 3) 
~easured in ppm downfield from TMS. 
39 
TABLE II 
13c NMR CHEMICAL SHIFTS FOR 25d AND SELECTED MODEL COMPOUNDS 
Model Compound 
CH 3 <CH 2 ) 10 CH 2 CH 2C0 2CH 3 
3 2 1 1 I 
@-CH 2CH 2CH 2C0 2 CH 3 
4 3 2 1 1' 
@-CH 2CH 2CH 2CH 2 CH 2CH 3 
1 2 3 4 5 6 
·~H2CH 2 CCH 2 ) 7 CH 2 CH 2 C0 2 CH 3 








































COMPARISON OF 13c NMR CHEMICAL SHIFTS REPORTED FOR ?.22 AND ~ 















1 173.6 173.8 174.0 
2 35.8 36.0 34.1 
3 24.6 24.8 24.9 
a 33.8 33.9 30.9 
6 30.2 30.6 36.2 
for these carbons unequivocally. In the first experiment, the 
decoupler on the NMR was set at a frequency such that only H(2) 
of 25d were irradiated. In the resulting 13c spectrum, all of 
the signals in the aliphatic region, with the exception of the 
one at 34.1 ppm, were shortened and broadened due to coupling with 
the attached protons. The signal at 34.1 ppm appeared as a·single, 
sharp peak. Since this experiment was performed by selectively 
decoupling only H(2), the signal at 34.1 ppm was assigned unequi-
vocally to C(2) of 25d. This agrees with the assignment made 
initially for C(2) of 25d using model compounds (Table II). 
In the second selective heteronuclear decoupling experiment, 
the decoupler was set at a frequency such that only H(l2) (a to the 
anthracene ring) were irradiated. 13 In the resulting C spectrum, 
all of the signals in the aliphatic region, with the exception of 
the one at 36.2 ppm, were shortened and broadened due to coupling 
with the attached protons. The signal at 36.2 ppm appeared as a 
single, relatively sharp peak. Since this experiment was performed 
by selectively decoupling only the protons of 25d, the signal at 
36.2 ppm was assigned to C(ll) in 25d. The results of both selec-
tive heteronuclear decoupling experiments indicate that the assign-
ments made initially for 25d using model compounds are correct. 
41 
Further evidence that the correct assignments were made initially 
for C(2), C(ll), and C(l2) in 25d using model compounds was obtained 
from an heteronuclear correlated 2-dimensional (HETCOR 2-D) NMR 
experiment (Figure 9). This experiment was performed in the 13c 
1 
region between approximately 20 ppm and 37 ppm and in the H region 







of Figure 9 the proton decoupled C spectrum for 25d in this region 
is shown, while in the upper portion of Figure 9 the proton spectrum 
in this region is shown. If all of the peaks in the HETCOR 2-D 
spectrum .are compressed into one horizontal plane, the spectrum 
obtained is identical to the 1H spectrum shown. If the 2-D spectrum 
is observed from the right-hand side, and all of the peaks are com-
pressed into one vertical plane, the spectrum obtained is identical 
13 
to the C spectrum shown. 
An HETCOR 2-D experiment can be used to correlate the 1H signal 
for a particular set of protons with the 13c signal for the carbon 
23 
to which those protons are attached. In order to utilize the 
information contained in the 2-D spectrum, either the 1H or 13c NMR 
spectrum must be assigned unequivocally. In this case, the 1H NMR 
spectrum of ~ was assigned using labelling and homonuclear de-
coupling experiments as discussed earlier. From these techniques, 
1 the triplet at 8 2.78 in the H spectrum was assigned to H(12). 
Using the HETCOR 2-D spectrum it was found that these protons were 
attached to the carbon giving a signal at 36.2 ppm in the 13c 
spectrum. The signal at 36.2 ppm was, therefore, assigned unequi-
vocally to C(12). Similarly, the protons, H(2), that gave a triplet 
1 
at 8 2.28 in the H spectrum were attached to the carbon that gave 
a signal at 34.1 ppm in the 13c spectrum. The protons, H(ll), that 
gave a multiplet at o 1.62-1.74 in the 1H spectrum were attached 
to the carbon that gave a signal at 30.9 ppm in the 13c spectrum. 
1 
The protons, H(3), that gave a multiplet at 8 1.48-1.62 in the H 
spectrum were attached to the carbon that gave a signal at 24.9 
13 




gave a multiplet at o 1.1-1.4 in the H spectrum were attached to 
the carbons that gave signals between 29.1 and 29.5 ppm in the 13c 
spectrum. The assignments made using the HETCOR 2-D experiment 
were identical to those made using the model compounds and selective 
heteronuclear decoupling experiments. The assignments shown in 
Table I for C(l'), C(l), C(2), C(3), C(a), and C(S), where C(a) and 
C(S) refer to C(l4) and C(l3) in ~ and C(l7) and C(l6) in ~' 
were made by comparison to the analogous carbons of 25d. -. 
There is no reasonable explanation why the analogous carbons of 
25b and 25c should have drastically different chemical shifts from 
those determined for 25d. The results of the selective hetero-
nuclear decoupling and HETCOR 2-D experiments using ~ indicate 
that the assignments reported for C(2), C(a), and C(S) in~ and 
25 . 3 ~c were incorrect. The corrected assignments along with the T1 
3 
values reported for these compounds are shown (Table IV). Although 
~ contains a very short side chain and comparison to the longer 
homologs might ~e less valid, the assignments for C(2) and C(3) are 
almost certainly reversed. Again, the corrected assignments for 
25a are given (Table IV). 
The 13c NMR assignments for the carbons at the center of the side 
chains of 25d-25f were made using the corresponding 13c spin-lattice 
relaxation times (T1 values). In 25d-25f, an anthracene ring is 
attached to the terminal position of a fatty ester. The anthracene 
ring is very bulky and should, therefore, act as an anchor for the 
entire molecule. As a result of this anchoring effect, the mobility 
of the carbons attached most closely to the anthracene ring should be 
45 
TABLE IV 
CORRECTED 13c NMR ASSIGNMENTS AND Tl VALUES FOR ~-25c 
25a n=2, R=C 2H5 





1 172. 6 173.6 (37.2) 
2 31.3 33.8 ( 1. 7) 
3 35.5 24.6 ( 1.4) 
4 30.2 ( 1.1) 
5 35.8 ( 1.1) 
6 
7 
l' 60.3 51.3 ( 6.1) 
2' 14.2 
~easured in ppm downfield from TMS. 
bMeasured in seconds. 
b (T1 Value ) 
25c 
173.8 (38. 5) 
33.9 ( 1. 9) 
24.8 ( 1.4) 
28.8 ( 1.1) 
28.8 ( 1.1) 
30.6 ( 1.0) 
36.0 ( 1. O) 
51. 2 ( 6. 2) 
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greatly reduced. For carbons progressively further along the chain 
away from the anthracene ring, the freedom of motion should increase. 
In other words, the relative mobility of the methylene carbons in the 
side chain of 25d-25f should be smallest for the carbon attached to 
the anthracene ring and should increase progressively to C(2). 
This change in mobility along the side chain is reflected in the 
T1 values for each distinguishable carbon. Since a large T1 value 
indicates an increased mobility at a given carbon (assuming the same 
relaxation mechanism is operative for all carbons being compared), the 
T1 values for the methylene carbons in the side chains of the esters 
should be smallest for C(12), C(l4), and C(l7) of 25d, 25e, and 25f, 
respectively, and should increase progressively to higher T1 values for 
C(2) of these compounds. Using this trend, the assignments for C(4)-
C(lO) of 25d, C(4)-C(l2) of 25e, and C(4)-C(l5) of 25f were made as 
shown in Table I. These assignments have not been verified by isotope 
labelling experiments since the appropriately labelled compounds would 
be extremely difficult to prepare. Supportive evidence for the rather 
unusual trend in T1 values proposed here is shown in Table IV. When 
the assignments for the carbons in the side chains of 25b and 25c are 
corrected to reflect the results of the selective heteronuclear 
decoupling and HETCOR 2-D experiments using 25d, the Ti values of the 
methylene carbons of 25b and 25c exhibit the same trend. That is, the 
T1 values for the methylene carbons are smallest for the carbon 
attached to the anthracene ring and increase progressively to C(2). 
Unequivocal assignments for the signals in the aromatic region of 
the 13c spectra of 25d-25f are very difficult to make. Although other 
3,41 . 
workers have made assignments for the aromatic carbons in various 
2-alkylanthracenes, these assignments have not been absolutely con-
firmed. To assign the aromatic carbons in 25d-25f based upon the 
-~ 
assignments reported for the substituted anthracenes would not be 
defensible at this time. 
Tentative assignments for the aromatic carbons of 25d-25f are 
shown in Table V. The assignments shown for the protonated ·aromatic 
carbons of 25d were made using an HETCOR 2-D experiment (Figure 10). 
This experiment was performed between o 6.9 and 8.7 in the 1H domain 
d b 114 d 134 · h 13c d · an etween an ppm in t e omain. 
In order to use the information in this 2-D spectrum to assign 
the 13c signals for the protonated aromatic carbons of 25d, the 
corresponding 1H spectrum must be assigned. The assignments for these 
1H signals were made using the expected splitting patterns for each 
aromatic proton as shown in Table VI. It must be recognized, however, 
that some of these assignments are tentative and may be interchanged 
as noted. Using these 1H assignments and the HETCOR 2-D experiment, 
h 13c · d h ' T bl V t e assignments were ma e as s own in a e . Again, it must be 
recognized that some of the assignments may be interchanged as noted. 
It was possible to identify the 13c signals for C(3), C(4), C(6), and 
C(7) unequivocally. Since H(3) and H(4) were readily distinguished in 
the 1H spectrum by their splitting patterns, the 13c assignments for 
the corresponding carbons were established using the HETCOR 2-D 
spectrum. The 1H signals for H(6) and H(7) overlapped and could not 
be distinguished. The HETCOR 2-D experiment indicated that C(6) and 
13 
C(7) gave signals at 124.6 and 124.9 ppm in the C spectrum. The 
47 
assignments for these carbons were made unequivocally using spin-lattice 
relaxation time measurements (Table V). As noted earlier, a protonated 
48 
TABLE V 
13c NMR ASSIGNMENTS (Tl VALUES) OF AROMATIC CARBONS OF ~-25f 





Shifta (T1 Values 
Number 
25d 25e 
lb 125. 5 ( 1. 30) 125.5 ( 1.43) 
2 139.6 (14. 3) 139.5 (14.0) 
3 127.3 ( 1.05) 127.3 ( 1.16) 
4 127.8 ( 1. 28) 127.8 ( 1.46) 
Sc 127.9 ( 1. 30) 127.9 ( 1. 48) 
6 124.6 ( 0.71) 124.6 ( 0.58) 
7 124.9 ( 1.11) 124.9 ( 1. 33) 
Sc 127.8 ( 1. 28) 127.8 ( 1. 46) 
9b 125.1 ( 1. 34) 125.1 ( 1. 38) 
lOb 125.7 ( 1.46) 125.6 ( 1. 43) 
4ad 131.6 (25.1) 131.6 (25.4) 
Sad 130.4 (24.3) 130.3 (22. 7) 
9ad 131.0 (23. 8) 131.0 (26.4) 
lOad 131. 8 (23.5) 131.7 (26.8) 
'\ieasured in ppm downf ield from ™S· 
b May be interchanged. 
~ay be interchanged. 
~ay be interchanged. 
(sec)) 
25f 
125.5 ( 1.48) 
139.6 (13. 9) 
127.3 ( 1. 21) 
127.8 ( 1. 43) 
128.0 ( 1. 40) 
124.7 ( 0. 71) 
125.0 ( 1.25) 
127.8 ( 1. 43) 
125.1 ( 1. 44) 
125.7 ( 1. 38) 













Figure 10. HETCOR 2-D Spectrum in the Aromatic Region for ~2£ 
TABLE VI 
1H NMR ASSIGNMENTS FOR THE AROMATIC PROTONS OF 25d 
Proton Expected 





6 ddd or pseudotriplet 




aAssignments may be interchanged. 
bAssignments may be interchanged. 
Observed 




7. 89- 7. 96 
7. 35-7. 42 
7.35-7.42 















cs=singlet, d=doublet, dd=doublet of doublets, t=triplet, m=multiplet. 
carbon along an axis of symmetry in an aromatic molecule can be 
identified by its short T1 . In 25d an axis of symmetry can be drawn 
through C(2) and C(6). The assignment for C(6) was made by comparison 
25d 
of the measured T1 values. The carbon giving a signal at 124.6 ppm 
had a T1 value of 0.71 seconds; whereas, all of the remaining aromatic 
carbons had T1 values of greater than 1 second. The signal at 124.6 
ppm was therefore assigned to C(6) leaving the signal at 124.9 ppm 
to be assigned to C(7). The assignments for the aromatic carbons of 
25e and 25f were made by comparison to 25d (Table V). Again, some of 
these assignments may be interchanged as noted. 
Suggestions for Future Work 
The synthesis of ~-~ opens the door for the development of 
many related fluorescent probes which are potentially even more useful 
in studies of biological membranes. The probes 48-50 are the most 
obvious choices for expanding this new class of probes. The syntheses 
of 48 and 49 should be straightforward while synthesis of 50 will be 
more challenging. Finally, fluorescence experiments using 25d-25f 
as probes of biological membranes should be performed to determine 
whether these compounds are, in fact, suitable for this purpose. 
51 
52 





Reactions were carried out under a nitrogen atmosphere where 
necessary. All reactions were stirred using a magnetic stirrer unless 
otherwise specified. During work-up, solvents were removed using a 
rotatory evaporator unless otherwise stated. NMR spectral data was 
obtained using either a Varian XL-100(15) NMR equipped with a Nicolet 
TT-100 PFT accessory or a Varian XL-300 NMR. All NMR data was reported 
in ppm downfield from TMS using either TMS or CDC1 3 as an internal 
reference. IR spectral data was obtained using a Perkin Elmer 681 IR 
spectrophotometer. Melting points were determined using a Thomas Hoover 
melting pain~ apparatus and were uncorrected. 
Starting Materials 
The following starting materials and special reagents were pur-
chased from the source listed and were used without further purification: 
2-methylanthraquinone (Aldrich, mp 170-173°C), 11-bromoundecanoic acid 
(Aldrich, mp 48-51°C), 11-bromoundecanol (Aldrich, mp 46-49°C), dihydro-
ambrettolide (Columbia), pyridine-~-oxide (Aldrich, mp 60-64°C), and!!_-
BuLi/hexane (1.6 M, Aldrich). Dry solvents were obtained as discussed 
below. Benzene, toluene, and diethyl ether were distilled from sodium 
prior to use. THF was freshly distilled from LiAlH4 . DMF was dried 
53 
over P2o5, decanted, and distilled under vacuum. DMSO was distilled 
under vacuum from CaH. 
2-(Hydroxymethyl)anthracene (37) 
2-(Hydroxymethyl)anthracene was prepared from 2-methylanthra-
6 14 22 25 53 . . . quinone (36) using published procedures ' ' ' ' in a yield of 45%. 
2-(Bromomethyl)anthracene (38) 
54 
Bromine (1.5 mL) was added dropwise under N2 to a stirred solution 
of triphenylphosphine (7.0 g, 26.72 mmol) in dry DMF (40 mL) in a 
100-mL round bottom flask. The alcohol 37 (5.0 g, 24.04 mmol) was added 
as a solid to the resulting orange suspension. After 5 min, a pale 
yellow solid precipitated. After stirring for an additional 75 min, 
the yellow solid was filtered (vacuum). A second crop of the solid 
was obtained by cooling the filtrate to o0 c for 4 h. The combined 
solids were recrystallized (CHC1 3) to give 5.48 g (84.1%) of 38 as a 
0 . 34 0 1 pale yellow powder: mp 198.5-199 C (lit. 160 C); H NMR (CDC1 3) o 
4.79 (s, 2 H, cg_2Br), 7.24-8.37 (m, 9 H, Ar-!!_); Anal. Calcd for 
c15H11Br: C, 66.45; H, 4.06; Br, 29.49. Found: C, 66.1; H, 4.16; 
Br, 29.52. 
(2-Anthrylmethyl)triphenylphosphonium 
Bromide (33) 34 
A solution of 38 (1.7 g, 6.27 mmol) and triphenylphosphine (1. 7 g, 
6.49 mmol) in dry benzene (75 mL) was heated at reflux under N2 for 24 
h in a 200-mL round bottom flask equipped with a condenser. The mixture 
was cooled and filtered. The resulting solid was reprecipitated from 
CHC13 using anhydrous ether, washed with dry ether (50 rnL), and dried 
under vacuum to give 3.0 g (89.8%) of 33 as an off-white powder: mp 
0 1 + 
> 220 C; H NMR (CDC1 3) 8 5.54-5.68 (d, 2 H, CH 2P ), 7.0-8.2 (m, 24 H, 
Ar-H); 31P NMR (CDC1 3) 22.9 ppm.(85% H3Po4 reference). 
Methyl 11-Bromoundecanoate (40) 
A solution of 11-bromoundecanoic acid (39, 20.0 g, 0.103 mol) and 
cone. H2so4 (2 mL) in methanol (200 rnL) was heated at reflux under N2 
through 3 ~ molecular sieve for 48 h in a 500-mL round bottom flask 
55 
equipped with a Soxhlet and a condenser. The solution was concentrated 
to a volume of 50 mL, diluted with ether (50 mL), and washed successive-
ly with 10% aqueous NaHco 3 (2 x 50 rnL), u2o (25 rnL), and saturated 
aqueous NaCl (25 mL). The solution was dried (Na2so4), and the solvent 
was removed. Vacuum distillation gave 15.8 g (75%) of 40 as a clear, 
colorless liquid: bp 93-96°C/0.025 nun (lit. 12 126-128°C/0.65 mm); IR 
-1 1 (neat) 1740 cm (C=O); H NMR (CDC13) 8 1.28-1.9 [m, 16 H, (CH2) 8], 
2.29 [t, 2 H~ c!!_2co2Me], 3.39 [t, 2 H, CH2Br], 3.64 [s, 3 H, OC!!.31; 
13 C NMR (CDC1 3) ppm 173.9 [C(l)], 51.3 [C(l')], 34.0, 33.8, 32.8, 29.3, 
29.1, 29.1, 28.7, 28.1, 24.9 [C(2)]. 
Methyl 11-0xoundecanoate (34a) 56 
A mixture of 40 (7.0 g, 25.1 rnmol), pyridine-N-oxide (4.8 g, 
50.5 mmol), and NaHC03 (4.2 g, 50.0 mmol) in dry toluene (32 rnL) in 
a 100-mL,round bottom flask equipped with a condenser was heated at 
reflux under N2 with vigorous stirring for 6 h. The resulting dark 
brown mixture was cooled, washed with H2o (2 x 25 mL), and dried 
(Na2so4). Removal of the solvent (vacuum) gave a dark brown oil which 
was distilled (vacuum) to give 3.7 g (69%) of 34a as a colorless 
0 -1 1 
liquid: bp 95-98 C/0.05 mm; IR (neat) 1720-1740 cm (C=O); H NMR 
(CDC1 3) 8 1.3-1.7 [m, 14 H, (CH2) 7], 3.23-3.5 [m, 4 H, H(2), H(lO)], 
3.66 [s, 3 H, OCH3], 9.74 [t, 1 H, C.!!_0]. 
Methyl 12-(2-Anthryl)-ll-dodecenoate (35a) 
A solution of 33 (2.5 g, 4.69 mmol) in anhydrous DMSO (65 mL) was 
56 
added dropwise with stirring under N2 at room temperature (RT) to a 50% 
mineral oil dispersion of NaH (0.25 g, 5.208 mmol) in a 250-mL round 
bottom flask. The resulting blood-red solution was stirred at RT for 
10 min. A solution of the aldehyde 34a (1.9 g, 8.879 mmol) in dry DMSO 
(5 mL) was then added in one portion. The mixture was stirred for an 
additional 48 h at RT, diluted with H2o (150 mL), and acidified (litmus) 
with cone. HCl. The resulting yellow solid was filtered (vacuum) and 
air-dried in the dark. The solid was digested twice with 95% ethanol 
(50 mL) and dried in the dark to give 1.4 g (76.9%) of 35a as a light 
0 1 yellow powder: mp 121->250 C; H NMR (CDC1 3) 8 1.2-1. 7 [m, 14 H, 
(CH2) 7], 2.18-2.62 [m, 4 H, CH=CHC!:!_2 and C_!!2co2Me], 3.63 [s, 3 H, OC_!!3], 
6.34-6.56 [m, 1 H, ArCH=C.!!_, trans], 7.22-8.35 [m, 10 H, Ar-Hand ArC!:!_=CH, 
trans]. A small amount (~23%) of the cis isomer was present as indi-
cated by 1H NMR signals at 8 5.6-5.94 [m, ArCH=C.!!_, cis] and 6.6-6.7 [d, 
ArC.!!_=CH, cis]. The wide mp is probably due to the cis-trans mixture. 
Methyl 12-(2-Anthryl)dodecanoate (25d) 
A solution of 35a (0.4 g, 1.031 mmol) in ethyl acetate (75 mL) was 
hydrogenated at RT and atmospheric pressure in the presence of 10% Pd/C 
(0.1 g) for 4 h. Addition of diatomaceous earth followed by vacuum 
57 
filtration and evaporation of the solvent gave an off-white solid. The 
solid was recrystallized (95% ethanol) twice and then subjected twice 
to molecular distillation (110°C/5 x 10-4 mm) to give 0.3 g (74.6%) of 
25d as a white powder: 0 0 1 mp 104.5 -105 C; H NMR (CDC13) o 1.29-1.9 
[m~ 18 H, (C_H2) 9 ], 2.28 [t, 2 H, C.!!_2co 2MeJ, 2.78 [t, 2 H, ArC.!!_2 ], 3.64 
[s, 3 H, OC.!!_3], 7.21-8.34 [m, 9 H, Ar-J!]; Arial. Calcd for c27H34o2 : 
C, 83.08; H, 8.72. Found: C, 83.02; H, 8.99; Mass spectral data for 
+ m/e (M ) 390.2559; Found: 390.2550. 
Methyl 13-Hydroxytridecanoate (42) 
A solution of ~-butyllithium in hexane (1.6 M, 44.3 mL, 70.88 
mmol) was added dropwise under N2 to a stirred solution of 2,4,4-tri-
methyloxazoline (8.0 g, 70.796 mmol) in dry THF (80 mL) at -78°c in a 
500-ml round bottom flask. The solution was stirred at -78°C for an 
additional 10 min .at which time a solution of lithium 11-bromoundec-
oxide in THF [generated by treatment of 11-bromoundecanol (17.8 g, 
70.94 mmol) in 45 mL of dry THF with n-butyllithium in hexane (1.6 M, 
44.4 mL, 71.04 mmol)] was added dropwise. The mixture was stirred at 
-78°c for 10 min and at RT for an additional 2 h. The mixture was 
poured into ice water (250 mL), acidified (litmus) with cone. HCl, and 
extracted with ether (100 mL). The aqueous layer was neutralized with 
cooling (ice bath) using 40% aqueous NaOH and extracted with ether 
(3 x 100 mL). The organic layer was washed with saturated aqueous NaCl 
(2 x 100 mL) and dried (MgS04). The solvent was evaporated to leave 
41 as a tan oil which solidified upon cooling (15.95 g, 79.1%). A 
solution of the crude oxazoline 41 in CH30H (300 mL), H20 (10 mL), and 
cone. H2so4 (12 mL) was heated at reflux in a 500-mL round bottom flask 
58 
for 18 h. The solution was concentrated to 75 mL, poured into cold 
H20 (150 mL), and extracted with ether (2 x 100 mL). The organic layer 
was washed successively with 5% aqueous NaHco3 (2 x 100 mL) and 
saturated aqueous NaCl (2 x 100 mL) and dried (Mgso4). Removal of 
the solvent left a tan oil which solidified upon cooling. Recrystalli-
zation (petroleum ether), with cooling to o0 c, gave 8.2 g (47.5%) of 
42 as a white solid: 0 • 33 0 mp 38.5-39.? C (lit. 40.5-41.5 C); IR (melt) 
-1 1 -
2900-3600 (OH), 1740 cm (C=O); tl. NMR (CDC13) 8 1.28-1.7 [m, 20 H, 
(C!!_2) 10 J, 1.8-1.9 [br s, 1 H, OH], 2.42 [t, 2 H, C!!_2co2Me], 3.58-3.70 
13 
[m, 5 H, OC.!!_3 and C.!!_20H]; C NMR (CDC1 3) ppm 174 .1 [ C(l) J, 62. 9 
[C(l3)], 51.3 [C(a)], 34.1 [C(2)), 32.8, 29.6, 29.5, 29.4, 29.3, 29.2, 
29.1, 25.7, 24.9 [C(3)). 
Methyl 13-0xotridecanoate (34b) 41 
Chromium trioxide (6.2 g, 62.00 mmol) was added under N2 to a 
stirred solution of pyridine (9.7 g, 122.8 mmol) in CH2c12 (150 mL) in 
a 300-mL round bottom flask. After 20 min, a solution of the alcohol 
42 (2.5 g, 10.25 mmol) in CH2c12 (20 mL) was added in one portion. 
After stirring for an additional 20 min, the solution was decanted, 
and the tarry residue was washed with ether (2 x 75 mL). The combined 
organic solutions were washed with 5% aqueous NaOH (4 x 100 mL), 5% 
aqueous HCl (2 x 100 mL), saturated aqueous NaHC03 (2 x 100 mL), and 
saturated aqueous NaCl (150 mL). After drying (Mgso4), the solvent 
was removed to give 2.38 g (96%) of crude 34b as a light yellow oil. 
The aldehyde 14b was used in subsequent reactions without further 
purification. 
-1 1 
IR (neat) 1720-1740 cm (C=O); H NMR (CDC1 3) 6 1.2-1.7 
[m, 18 H, (C.!!_2) 9 ], 2.2-2.5 (m, 4 H, CH2co2Me and C!!_2CHO), 3.66 (s, 3 H, 
OC!!_3), 9.74 (t, 1 H, 
[C(l)J, 51.3 [C(a)J, 
13 
G_!!O); C NMR (CDC13) ppm 202. 6 [C(13)], 174. 0 
43.8 [C(l2)], 34.0 [C(2)], 29.4, 29.35, 29.3, 
29.3, 29.1, 24.9 [C(3)}, 22.1 [C(ll)]. 
Methyl 14-(2-Anthryl)-13-tetradecenoate (35b) 
A solution of the phosphonium salt 33 (2.0 g, 3.753 mmol) in dry 
DMSO (75 mL) was added rapidly under N2 to a stirred 50% mineral oil 
dispersion of NaH (0.2 g, 4.167 mmol) in a 100-mL round bottom flask. 
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The resulting blood-red solution was stirred for 10 min, and a solution 
of the aldehyde~ (1.4 g, 5.785 mmol) in dry ether (5 mL) was then 
added in one portion. The resulting mixture was stirred for 24 h at 
RT, diluted with H20 (75 mL), and acidified (litmus) with cone. HCl. 
Vacuum filtration gave a bright yellow solid which was digested in 95% 
ethanol (50 mL) and air-dried in the dark (1.4 g, 89.7%): mp 108->250°C; 
1 
H NMR (CDC13) 8 1.04-1.76 [m, 18 H, (CH2) 9J, 2.12-2.58 [m, 4 H, 
CH=CHCHz, CH2C02CH3J, 3.63 [s, 3 H, OC.!:!_3], 6.32-6.54 [m, 1 H, ArCH=CH, 
trans], 7.24-8.36 [m, 10 H, Ar-.!:!_, ArCH=CH, trans]. A small amount of 
the cis isomer was present as indicated by 1H NMR signals at 8 5.58-5.9 
[m, ArCH=CH,' cis] and 6.56-6.69 [m," ArC.!:!_==CH, cis]. The wide mp is 
probably due to the cis-trans mixture. 
Methyl 14-(2-Anthryl)tetradecanoate (25e) 
A solution of ~ (0.5 g, 1.202 mmol) in warm ethyl acetate (150 
mL) was hydrogenated at atmospheric pressure in the presence of 10% 
Pd/C (0.1 g) for 4 h in a 300-mL hydrogenation flask. Diatomaceous 
earth was added, and the mixture was filtered. Evaporation of the 
solvent left a pale yellow solid. Recrystallization (95% ethanol) 
(twice) and molecular distillation (110°c, 5 x 10-4 mm) (twice) gave 
60 
0 1 0.4 g (79.6%) of ~ as a white powder: mp 103-103.5 C; H NMR (CDC13) 
o 1.2-1.7 [m, 22 H, (C_!!2) 11 J, 2.27 [t, 2 H, C_!!2co2Me], 2.78 [t, 2 H, 
ArC!!_2J, 3.63 [s, 3 H, OC.!!_3 ], 7.2-8.34 [m, 9 H, Ar-H]; Mass spectral 
+ data for c29H38o2 : m/e (M) 418.2872; Found: 418.2862. 
Methyl 16-Hydroxyhexadecanoate (44) 
A solution of dihydroambrettolide (43, 5.0 g, 19.685 mmol) and _E_-
toluenesulfonic acid (PTSA, 1.0 g) in methanol (250 mL) was heated at 
reflux under N2 for 18 h in a 500-mL round bottom flask equipped with 
a condenser. The solution was concentrated to 75 mL, poured into cold 
H20 (100 mL), and extracted with ether (3 x 75 mL). The organic layer 
was washed with 10% aqueous NaHco 3 (2 x 75 mL) and dried (Mgso4). 
Removal of the solvent left a waxy white solid. Recrystallization 
0 (petroleum ether, hp 37.7-56.9 C) gave 4.8 g (85.3%) of 44 as a flakey 
0 -1 white solid: mp 56-57 C; IR (melt) 2900-3600 (OH), 1740 cm (C=O); 
13 C NMR (CDC13) ppm 174.1 [C(l)], 62.8 [C(l6)], 51.3 [C(a)], 34.1 
[C(2)], 32.8, 29:6, 29.4, 29.2, 29.1, 25.8, 24.9 [C(3)]. 
Methyl 16-0xohexadecanoate (34c) 
Chromium trioxide (6.3 g, 63.0 mmol) was added under N2 to a 
stirred solution of pyridine (9.9 g, 125.3 mmol) in CH2c12 (150 mL) 
in a 300-mL round bottom flask. After 20 min, a solution of the 
alcohol 44 (3.0 g, 10.489 mmol) in CH2c1 2 (20 mL) was added in one 
portion. After an additional 20 min, the solution was decanted, and 
the tarry residue was washed with ether (2 x 75 mL). The combined 
organic solutions were washed successively with 5% aqueous NaOH (4 x 
100 mL), 5% aqueous HCl (2 x 100 mL), saturated aqueous NaHC03 (2 x 
100 mL), and saturated aqueous NaCl (150 mL). After drying (MgS04), 
the solvent was evaporated to give 2.5 g (83.9%) of crude 34c as a 
white solid. This solid was used in subsequent reactions without 
0 -1 
further purification: mp 67-69 C; IR (melt) 1720-1740 cm (C=O); 
13 
C NMR (CDC13) ppm 202.4 [C(l6)], 173.9 [C(l)], 51.2 [C(a)], 43.7 
[C(l5)], 34.0 [C(2)], 29.5, 29.4, 29.3, 29.2, 29.1, 29.0, 24.8 [C(3)], 
22.0 [C(l4)]. 
Methyl 17-(2-Anthryl)-16-heptadecenoate (35c) 
A solution of the phosphonium salt 33 (2.0 g, 3. 753 mmol) in dry 
DMSO (75 mL) was added rapidly under N2 to a stirred mineral oil 
dispersion of NaH (50%, 0.2 g, 4.167 mmol) in a 300-mL round bottom 
flask. After 10 min, a solution of the crude aldehyde 34c (1.9 g, 
6.69 mmol) in dry ether (50 mL) was added to the blood-red solution. 
After stirring for 30 h at RT, the mixture was diluted with H2o (100 
mL) and acidified (litmus) with cone. HCl. The mixture was filtered 
(vacuum) to give a yellow powder. The filtrate was extracted with 
61 
CHC13 (3 x 50 mL). The organic layers were combined and dried (Na2so4). 
Removal of the solvent left a yellow semisolid. The combined solids 
were digested in 95% ethanol (40 mL) and air-dried in the dark to give 
0 1 1.4 g (81.4%) of 35c as a yellow powder: mp 110->250 C; H NMR (CDC1 3) 
o 1.1-1. 75 [m, 24 H, (C_!-!_2) 12 ], 2.17-2.6 [m, 4 H, CH=CHCH2 , CB_2co2cH3], 
3.65 [s, 3 H, OC_!!3 ], 6.55-6.8 [m, 1 H, ArCH=CB_, trans], 7.45-8.6 [m, 
10 H, Ar-_!!, ArCB_=CH, trans]. A small amount of the cis isomer was 
present as indicated by the 1H NMR signals at o 5.85-6.2 [m, ArCH=CB_, 
cis] and 6.8-6.9 [m, ArC!!.=CH, cis]. The wide mp is probably due to 
the cis-trans mixture. 
Methyl 17-(2-Anthryl)heptadecanoate (25£) 
A warm solution of 35c (0.5 g, 1.092 mmol) in ethyl acetate (175 
mL) was hydrogenated at atmospheric pressure in the presence of 10% 
Pd/C (O.l g) for 4 h in a 300-mL hydrogenation flask. Addition of 
diatomaceous earth, vacuum filtration, and evaporation of the solvent 
gave an off-white powder. The solid was recrystallized twice (95% 
ethanol) and subjected twice to molecular distillation (140°C/5 x 10-4 
0 
mm) to give 0.4 g (80%) of ~ as a white powder: mp 104.5-105.5 C; 
1 H NMR (CDC13) o 1.2-1.85 [m, 28 H, (CH2) 14 ], 2.29 [t, 2 H, C!!_2co2Me], 
2.79 [t, 2 H, ArCH2], 3.65 [s, 3 H, OC_!!3], 7.2-8.34 [m, 9 H, Ar-H]; 
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1 H NMR Spectrum of 40 
Solvent. CDC1 3 SO .. 85771 Hz; PW. 
P2/RF. • 60 µs/dB; SF. • 100.1 Hz; FB. 
Gated Off. Offset. Hz; RF. 
1000 Hz; T. • 
2 Hz; Lock. 
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13 C NMR Spectrum of 40 
PFT X CW : Solvent •• CDC13 . so. . 35101 Hz; PW. • 5000 Hz; T •• 30 °C; ' 
P2/RF. µs/dB; 
2 
Size. . 8 K; . 10 SF. . 25.2 Hz; FB •• Hz; Lock •• H . 
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H NMR Spectrum of ~ 
PFT cw _:;s ; Solvent. . CDC13 ; so. 85771 Hz; PW. . 1000 Hz; T. . 30 OC; Acq/SA. . 
Size. . K; P2/RF. . 58 µs/dB; SF. 100.1 Hz; FB. . 2 Hz; Lock. .~ . D5/ST. . 250 s ' 
DC. : Gated Off. . ; Offset. . Hz; RF. . W/dB; NBW. Hz °' '1 
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H NMR Spectrum of 35a -
CDC13 . so. . 85771 Hz; PW. ' 
60 µs/dB; SF. • 100.1 Hz; FB. 
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H NMR Spectrum of Z1 
CDC13 
59µs/dB; 
SO •• 85771 Hz; PW •• 1000 Hz; T. • 
SF. .100 .1 Hz; FB. 2 Hz; Lock. 
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H NMR Spectrum of 22d 
SO •• 85771 Hz; PW •• 1000 Hz; T •• CW _lC ; Solvent. 30 °C; Acq/SA. • 
Size. K; P2/RF. • ssµs/dB; SF. 100.1 Hz; FB. 2 Hz; Lock. 
2H D5/ST. 250 s 
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C NMR Spectrum of ~ 
' 
l~,~~11~1~~·~1~i~1~t(1'i~·~ 
PFT X CW Solvent. CDC13 ; SO .. 35101 Hz; PW •. 5000 Hz; T •. 
30 °C; Acq/SA •• 500 
Size •• SK; P2/RF.. lOµs/dB; SF •• 25.2 Hz; FB. 
' 2 
Hz; Lock. • H 
DC. • 1H ; Gated Off. • ; Offset •• 45051 Hz; RF .• 9 W/dB; NBW •• 
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1 H NMR Spectrum of 42 -
PFT cw 3; Solvent •• CDC13 . so . • 85771 Hz; PW. ' 
Size. . K· ' P2/RF. . 61 µs/dB; SF. • 100 .1 Hz; FB. 
DC. . Gated Off. • . Offset. Hz; RF. . . . . 
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13 C NMR Spectrum of 25e ,._ 
PFT X CW : Solvent. • CDC1 3 . so •• 35101 Hz; PW. . 5000 Hz; T • • 30 oc; Acq/SA. • 420 ' 
• 8 K; P2/RF. 10 µs/dB; Lock. 
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D5/ST. Size. . SF. • 25.2 Hz; FB. . Hz; • H . . 5 ' 
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C NMR Spectrum of 34c -
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Size. • 8 K; P2/RF. . 10 µs/dB; SF . . 25. 2 Hz; FB. . Hz; 




T. • 30 °C; 
Lock. • 2H . ' 
NBW. . 












ppm 180 160 140 120 100 80 60 
-ii .. :1:- I ··:1;-;-~;1:-,:1:::;r:c;:;n:1:;11H:il-l·''l- 1 :'11 - /•'I·/ Hll-ll-H-HI 
-----:}~ 
1 
H NMR Spectrum of 35c -
PFT cw x. Solvent. • CDC1 3 . so. • 85771 Hz; PW . .1000 Hz; T, . - - , , 
Size. . K; P2/RF. . 58 µs/dB; SF. • 100.1 Hz; FB. . 2 Hz; Lock. 
DC. Gated Off. Offset. Hz; RF. W/dB; NBW. . . . . . . . . 




























. :tw.:i:~jBr•· r1+l'IF1-i- ll-
rt j'"; II* , llrn!r, lli:l:j 0;_1:1;.; 
30 °C; Acq/SA. . 



















err ---t.f _~t~-~- ~1 ~ 
-f T- - ~: :-tt ·.;_ ,_ 
~<CH) CO CH .: ·.t+ j:~·r 
 2 16 2 3 ~w ,r ct." 
-!+++ 
11 
·+ • _, p " .. • .. '·4[ c·i• ··'i !.. ' .. "' .,.,, ........ ,.,, ;J1 i.1·1·· "-1 .. ~ .. -· ·! .r:·i: :i.1. ':" £'; •·'"''ITT! [ .. i· .J .. + .. I .•• T ".' r' '. "' . '.. .. . I .. , " • ". [1 !"· H .. , • '. ,. r• .er • ·t f -i' '·'" .... .,.. "'' :j:j::!:- I- • ;.:-i~- r+:;-:- .-;=:-t-r: ~~:~-t -~:-1:. : 1 !' :-:-; :-.:·.:; : .:.: 1 1~·:1 ; : :-; i._;- ;. -r~: . ;..~~=-l: lfl - + :r :r.-1 .tt'- - -;..++ -- ;::-::;· +t+~: ,..ti 
fEr#:E:hl±~Jt~}~~ gi~i- E:~~ -~a~- ~~~-~l~1i:Jdfi~t~ -~:~~t :~~J $- ~. t>~ -~tti-E~:J4~-~tl-
+-~--- +:, ri·· -~-.I i.-1-.1-· t·~~ j.l.-r •• 1 ........ 1- ,;_~-I rr--~--HI ;.,., ··I·~[ !----1-il l- r g '"'j" -1-··-· i'"' 
+_::±'~-'·rt ++ ,-c~J·1-· .. , ... q ,.,., ; ........... , .• ,,,, ,,,. ,,, ·"-··''" ·'1U t-1' · · -+r ''"':;:•!.+ 
~H= t=lr·f.r..i:"t:-j ·r::t:1.~;...!.:L; .. -1T:·~ ;·!;:r :.:-:.~ ~:::· ;-;~:. tq: t·~!~ .;.:1: 1r! t~-r.~- 11-L1 ±:r·. ·_ t1.;._: tft.T +~: 
,_,,_.,:' "'' '"1.l ,.;., 'ir• 'H• "-.- -'.J:J ..... ,. ;,,-j,...t· .,, .. .,.,. "'1··tc' 1·r·•t ·'ct··'"' ,. t' 1, ..... , ... ""it .... .;'., .. , ... ,., ....... ;, .... : .,.f ... - .. ["" ·;+«1 -·" :1 ;,; t+ 1-.h··'-'-' rt,. tr'! 1-·+-t +r++ ~!- ·~..-r·_ti·_; ~~r;..:::.;; =·--· ·+:-...: ·· :1·~ ,...:H- ~:;:1 :~ t+-Lr i·H-i-- ;t.i:,_ · :-::-r +-~t+-, .~r 
:!:::;:ftf·i::t++t':tt.·m:'-.r1 ~r•t lei.: ;:.::·ti.::; ';·:f· L;rr :~.t ::t.< i:C::.t. '.l.fi P 1.:cft· ;L.-j lf~~;"'f1· ct.'l'. +·r ' n . ttt ++.i .i., .. : __ ,, '"'' .... : ,,. i1,, 1"1'1 ···!1· ···~ .,.,, 1.hr+L'-+. I .-H .. - . '"± 
··-'-· -.- ·--It- ...!.f--1--p·•: r•:· rt-!• .. ;: :r:1 ·r··t i. 'T'" ; ' 1---1 · · !·HI !-'· 1 1.-~. -i- L.'-
·ty :tp: ~-- .. •+ ·'r i ... ,, ·"•t 1·•1·1· , .. 'r r•-i' .... ,. +ffiT ' l±t' +t·r I .. 1· tJ-LL I :t rR=f! lU . f.. l ...t:: I- .t. . :n. ·r:..~t ~, :_: -=-~:: r ~7~.. -~• ., t ·_,_ p::~J :.: t1 q: . -- -i:~rf r-r-. ·i-1.i· - . -t H: _.: ..,., . , . .,.,.. .~.J+ ... :a;: .. ,., ... , ..... +, . .,.,,.,.,!.., .... , ,.•,1 p.cr + .t;,tt., ..... Et,. .... :it 
00--m· + :j:t m·ir 1:::~· ua1 , .. :,,;;. 1;:-t' ~i, Jn .. f1 ... [. iH:', ·m·· ... 1 . .1. -~ H·J;::.-1.-·+ 11ii-~-1 .. w±t · . · l ···er "ii.' ., . ., : 1· h · -1 .. , ; · • I .[ !· I r". !· ' ,.,.. · · .r C ff ·n · ·I t '.f: + .,._ r ti· ·- · r -+-· '-! . .., • ; ·, • i-1 • • • ··t · 1 , .. ,, -· 1 ·" 1 •• ! i ·· 1 _ - -~ I _....... ;..;... •··-o:: f ·l- + t-t·f 1· 
;:p··1~+ r. it i+!J:l'TP .i:t.iJ ~it; :.;.;j j;c:~ .. l.<~·tj~I ti'' .. ,:.t {!'I"·· 1; J i'I lt- Lif-t' :ai .... t 
iJ:ij 4-1l - .=~++ +t=:-~._;tt '.ltl ~~q ;_;_:r r:.;; ~tf r:L! -,:·;·i ~·tj :r.t· i:t .(.1..l-·tJ:: ·:--lT ·'Tl~-
tff, .. ,.Efl:"ff'·: i~'T ·:~r-'i.~fffi~.W~ ::.Lr .•.t;· .~I.! "11 ~~·1 '.-'.Lt f~f l:".j .. n'.qt .. :~Fi=I :L;.t J I . ' .,,-+J j,.t ,;. .. ·c•i·jt:r. !-'·.-[ !.:...[. "I"· 1' ,.,1,. "'r' .,.,IT ·! .. Ir f.>L,lf ·:Li-•~· +; l' ·ff1= · · ·rtfT T~T i+H ·•·+ l· ·-r rL-·r ' · -+!• ~t.; -1-1!··· - -;.t- t+I- ,- - T 
ru·• ~j· tt '.rU9·1l:' '''i' t+I! 1i"8 ··.r ,,,., "'' ·p,?·,·r·1 .,., ·1•t1·1tr6···t H +r]i' »5 rp·' 1£Lt -- · .i.-~~ :-.~·: :· 1J 1:i:v ,r~; .:.! ;..r:;: ~~:·. ·· ·. ···Lr : __ : 1 ~-t:~. t:r .. ,_1.·: - r.~ :· .. -tt~ :): r i .,tJ.tHr;' ,1 ti f.f.! f d :+•:· I"' ,m l mt ! lt., ~f:i~ 1 r1 .. iW-f ·I+. j ~ ... ,eH + d1118: 4 
1 H NMR Spectrum of 25f --
+++· 
W.l.f:l .. ,.tli.c' 
. 8-fh=!ill± 
f~~imm...;1~ t·N;·· 
PFT cw x ; Solvent. . CDC13 ; so. • 85771 Hz; PW. • 1000 Hz; 
Size. . K; P2/RF. . 59 µa/dB; SF. • 100.1 Hz; FB. . 2 Hz; 
[+ 













• H . ' 
Gated Off. Off set. Hz; RF. W/dB; NBW •• DC •• . . . . . . . 
20 
1. .. o 
Acq/SA. 










180 160 140 120 
PLATE XXIII 
100 80 60 
ftflll-Eftlmm:am:ttl!l 
200 o· 
- t~ :-:.t "l-
t:l t:! - 'i a· o 'o ~ttmt-t!tltJ-i:J±J:JEttt 




4 0 0 l-H+++++H-1-H-l-H-1-l+l+H-i+li:~-
. 'c _ + ~ r n-n-t:l:tt!-l:l:l::l:l:i:±+t-j:j:j:j:j:j:i:t±l±±i ' ' 1 ' ' I± · 
-~1 -1 . ~ 20 O ':J=t-l::j:.j:tf-l:t',::j:j_f:f.:ttt:ltrn:H:if:t_j:j:j:j:f:l:l:l O O ::f:lli]:f! 
20'0' 
ffi :nr1-11 1·11 ··-· .... I' 1' 1 "I ···r 11'·1- ll"fT'TT-ilr{ "H- + ., .. ·11- ·'··-· 1'-"''':fiJ!-· -IEI ILJ1--- - f :f:l r+tt h +~fffl-' - - -  ""I"',., ,, ·-1 ''I !1· , , :,-111 ,, --•· 11·1 '"'+·· ··i-!· r··-;H - t ···-···n:r:i -:1- -0-rm-- - :i:rt ,, __ r 1 .!.- t:·: 1.1 ~i_µ.11)~ :;. it~ 11rr 1·.1· 1:.! :;-r ;'-~ .. ,1. 1 1r1-!.l ;~-~: .r.t; rtt: . -_ -·-L}-_H+1 ·. -.i..:i·.- : ------w-i=-1:.j: -i:I 
J~- _, 1 ,,. 1;_11,, ui·1-r--, 1,TTf1~',ll 11.1 I' . 11 ,.1.,11 ·" . 1,· ,_n_ -·-· ····w-:H·"· - ,_. 1-,-- 1,.1 ri- . i± fl -1--·, µ=f;-·-1-- !- - - it I ~' •·I ' '"T ··' i·t •·'I 1r r -· ·~t·- "-1- ~hi ·t H ·i-•-1- ·• '· - ·· · ·!- -r- - -· • - 1 -- 11 +-1- -r' 1-.i I,. r,; "'" 1-·1 1'·" i I Ht 1 •. r''I J+. ' . If" - .,.,, [,.,, r.-+1 -1 t- ·+'-'- . I •:' -·- 'H· - -·- :L- .. , + '· 
· - r ·+ _.-ii· · .. ~~ "· 1 · i 11 1 • 1 '' ti t i · 1 '•· 1-t :· ·· -~1 ~-1· · H+ H ~~ -, ,- ·· r --fl--l -11 ; r :- · ·• -· ·~1- +- - r - , -
~ - '-r! _,, t·~ c•·•4 ··I·' ti .. -; "-·j 1····- ''f'-t :t-j·i '-·II 11-'j ... -1-,_+1. ··"' ·r"c:±- ·1···-t±t. +-•-t:1· :t1 "-±1 :!±: I j -ri -i" ''1 ·;h ,.. ··;• "I : .. , .. "I q ii f'-" ·::-;: T~ - ~ 1tr -ilflff-1'' --,-~ -' Etj ·'8: i--~ -r ~ =ti: , . ;· :!". ~: !:;1 ::~: :;:: :~:: :;;~ ::::; ~:-::::'!ti i:-t1 :T;: 1- ';i;r :;;- 1:~~f~:'. ~_,_ 1--:_:_ ~ -/ J,: (1:\_'.1h:'=: .: _:=~- = ,.- -, __ 
;I .,_,11 ._,JI 1---1 ,,., ,._ .• ,,,! '-·-·' --·- .,,, .1j 1 1-J1 1.1-j ---·J \:I-I_ 1 ... 1-1,,+ jj .... l;-· i), 1 l, ±i-i· "'~ ·r,1:t tlH:lt--::'=_~,+- :Li_ _,_ttL t J -lH-i- -t-!-h- r-·-1-r ·-·-~: 1•~1 --·· ·-··· ·~l··-1 •••• 1' ·I .• , ·-1 _j:L:j . ·- •·;1-·· ... :-·· .. r··~ -1 11 , .. +1-·r-· r-t-lftrr}1- 1·.rrr .h- --l·++ 
I , "-[' ; .. !.' ... 1· "-·-··-· .... "i ., ·-· .. ,. -<! :-" "l-·-·1·1 :Fr'- "tl ,,,_ ., .. ·'· 1-IJ ~-~mi!TI!t' -t•J-i'. i-·. , .• ,_,_ ·1--· ··'' _,. .. ., 'ljl -·11 it'J :~I-- ··-·1- 'f-1- I'":·-·· !j-1· - -1- d· l 
Ii-~-·- t·~ .1~· t 4~-~1 !-:if L1: -!;~: '.!:; ·:'.'. ·~-.!.. :! ... _ ::.:,!-, ...._f- ... H t"t;~i :·:·:lf~i·: -i-J· t t-- H- , ·-: l 
H•- re• 1-1··' ' '' 1'•-· 11·· "" "r-· ···· ··• ·:.1." "'L ··-'·'· ·HH- ·' --, +-•- '·"-· _,_,, __ '(§ " i--r' 'I" ;--j+ ,,. _., 1!· .,., '-I I .... ·:· :.+'' ,. _,,I ··;1-t- . ,_, ·:•·'-1· +··· 1---fF -i-f 
·1·:-~T--t:r rr .. ,:t i:·i: ~:-1: ;:_!-; !t;; .... ·t:. ~;:; rrP rt-t- ;·:L :-p-~-- i-~r ;ct~;·-~· 1~J'=- i~r 
t~--·- !:Ill:! 1ft:I 
-mi~-
t_1um :m l~Clt~: i;~~ ~,ll ifjj iLl ~~-tif fr~r.~~t:~ii ~~:~-:I_ :--1ti~.}~i~,H~:~· 
-,+ 
t-1-!•l~i-.i H•.! •-•!I it-L· 1: 1 ~ ;~·1 1•+: ...... t- ... _;._., i-·t··: -r-1-1 1 Tl·, ·;H-1' Or·r· .; ·tj- ''-' § ,~ ..... j·H·i:-1 U'·t'..t :.-11 -··-1· 1--!·l-r 1~+· -·--1 -~·~ ::·1· 1~·-! ·--.-1 _, ... •:!• •11· ·~T ··c. ·r-.·1 ·1-i:t 1-i·i ... · i:H H···kt.t+_-
~~-.11-~-p/ ~ . ..r:tt :.::ti :.ti, ·;-_p-~ ~./::! :;-'..i :-.:·:; ·;-;~: trrj "l-:-.~ :1: •(! :;:-~-·t-, --·1t · - ·:1·t1. tr-Fi++:-
1-1; - '·' :.,-j .,~-' '-,-'-"·r'"·-'-·,[•--' --·l-----1·-'·'jc+ :·1--•-1 'ii_,..; -·J -H- .,.,,·-ln'~il'-!·1.. 1 ...... !·•·!~ .,.w.: -.-:-~ 1:T1 ·~_r, .. .,..; .. _._t.l •-·-1-_, f-.;.. r:-+1- r-i '..:J:i ·' -;·ttt.- -..·rt- ·-~_i-t·::r~t-'"· ·' 
+.~·zi_ :·;4~; tf+., ·r-t~ '-1"~;~ =~--t -1.:tF~ _; :-: .. , t:W--:.: · ~1-t -rf+:t- i--i :~~ ~I 1+-ft :~~ 1- lr .f::;-;· -htr ·., H+ 
13 C NMR Spectrum of 25c 
PFT X CW : Solvent •• CDC1 3 
. so. • 35101 Hz; PW. • 5000 Hz; T • • 30 °C; ' 
P2/RF. 10 µs/dB; FB. 
2 
Size. . 8 K; . SF. . 25, 2 Hz; . Hz; Lock. • H . ' 




















2.5 3 MICROMETERS 4 5 6 7 8 9 10 12. 14 16 
~· . , I . ·1~ ... - . , , .... • . • ..· • .• 'JGT'-'1.W...W-r .,...~:~ 1': ... ,, . T .,T , ilfTl d .. ,,,,,,, 100 E-r.;~ ·-t-----~-!-:- -~+:+;.; 1;-T!j '-. ·-:1-- ;-_..;.., 100., ~' ' ,1, ' • 't fTr1 -;.1·~~ -~- . -~, ~~--r 100;-r i 1- --~ -'.""'1" :IT. n ±IT j j l,~o,qr .;i rli--; ltt n, j 1 11 [ r • 11 , ! I 1 ••1' j 11 !" 11 IT "1 1.r /I' r 1 I,' •fj~ !' i t Ji; tr ir ti 1t ! r • 1 'I 11 1111 I .r rtH ~ +f· t 1·il 111 - f ~W,l"~l,1, :;.j "'; rh: l~l 11lq ,it llli f 1 tiuL1h :L· ,,,, :.;. ' .. l .,11 . Jj .,11liEi ~1..11 )~Hirn;;_ f!l!L ~,·1: '."'~,.:"'. '-.' ;~;;.::; ,'IJ 1.+111~1; t~ µ111 1± HOO. t11]HUHflfHhrr I" 1"1 1 111 'I' •1 11 Tt !+" Jl!j 'l'l"'r ''If"" J. I ' . ntlful I 'ITTlf ,, ''"' "ft'i1'1 ,[" I r,, ,1.I '" 1fti 1lf JJI' ttn ,.f lt I 1ffllffitlffimitt , I ... .";,r !Li ill I I 1·,1l'1,l I !'tl 'l' l I t ·1 I t' 11J1'11' 'i 11 ft 11'' IL ,  111;' II :1111' "II :I i,1, l If Ut I f . J,,l l~·•lft,.,, t l·tlrdP lr It It, I •t /, dJl'i,'l!i •ll 11 ·if I f flr'il· II tr"· l ], I~· 
I tti 1· nr: "1-1:~ u 1l1' ~I, jtl lllf " B: t Iµ ~ n n 'Hi l '.m :; H;f 11;11i!• w 'i!" '11'1 i ill t!.i rr1 I :1~~ rli-1 ~!l J. :1: 1 q:L h Fl Ltilf ~. !=I 11 tjf rtt· rj, f~lT·l 1 mt !if·' ~1 1 lit[j t·li 4+11 I u I i !;-; JI.I. i 
:';+tlr 11·:r 11l1 '++! l;ltJH+j ' 'I 11·w I '!' j·; 1111 11 Ml 11ri 1"11: 11 1 ri "" u•! I" ,+Li ~fi I ·hi fj, r I ·I w t ~ j . +HI ::rt T 1 nl lr;.r Iii 'lf ''I' Ii' i II I ltl [lrm1111 80 :~:; 11···,1'.: '1~ .:-ir1T1' ' - 8' . ~r:::·;. ,.: ~ j aonm-.:·!'.'~ r·r:, !~·a rm ... , 1. ,,, , . . ,. 1 r r 11 µ 1, . h , , 1'.,1 1 • 1~. 1, .. H 1, ,1. 1 JI 111 1 1 el: .!11 ::111,11HIit1fi,IH1 ~[1 rri l I'+· I I' n l ,, ' rt I ,,,t ·ii "i 1;flh! ·1 • l111~IH1! .!11 I I ' 11 .1 .1 ~.: I! t' • ; ,, ) I 11 · ·n f i r , -~ I i t t• ~ I T1 '11 r+trtti 't•w,I':• i ' 7'1 t 1 I• •1."1 rr1 ,i11 1 ,,, ·~ " " +, . I '' ,•: "i,. .' ;'11, 1 ,. 1l'iTirrl1 '"I, , 1 t1r. HH 1-f! r 1~ ~t , T r 1 1,H 'T , , "r ./H ·" j rn 1 I l' ~n H nJI [~I rlt1 f .ill tt >· H r11 l! I I t I l: .. l t I N!1 . r 1J,; • I :II. •it.··' iii •It! ::;1 ! 1 i ti I .I ,,,,.., tl·''"'miffi· l'l'ti111t'" I in~+i i ·' i I l 11 i1""'''ITTl·~·,·11,. ,.. t 1· it" I, r,f ri r d1jj'ffl I ,i Ir. l % r H1 'I t!• n1 I f j 1 t ' l I' l 'h:· fill i; ·.:; :1 i;li . 11 :ii!! I I ii fij '1° · 1 •11 i •1 1· l '• l !1 l , ·1 !:•• •, t l , TT r 1· n Tr 11 : • Hi ·r 1;1; 1 t I 1 ·. t .. · 1 1t:lffiiiF1~:;1i !1'!'1"1'! m;"1i·;j'.!f'·~ !r f11 ~\llilj[lt''!ll·' f li;!ff ih !: .. t.-+ 1rj1r jf IF[!. ii;:if1 1 ;11 ll\ •rrd·j'r;·mmm' i ' ,I·· . • I I I ' j I ! ' 11 l 1 • i· ' ! t ~ ' ' n • i - 1' I I- I r. l ' • -·· I . I •• ! i 11 r1 ·1 • tr. 11 r ' r ·lt~ .1! 1111, iii tr, . .,1. ,.;. :rl. 1. ,i, 1,, 1, ,1 .[6 · ,., H , ,f 1,nllr111 .. I,.,·" ri1l!r ii 1 f11, il•J ,PO'r ,1, ... I. "U 111 • :1 6611l U.·f!.l 60 Ii'' !II· " 1i1\ 'lj 111· i!1· ., I'"!' ii• 1· .. ,;, 111' 1i1 or i 1 I I ti I l't ! '" . "1"1! "'' H' t1 1'" 1 I ' 1·6 t 11 1'11 '!'' ,, "' '"1'm1 . ·rl I I 'i ~11 I! Ii ,, 11,1 'ii . .. . 1: ". 'i''" I"". 11'1 1·, "''',. '! . , 'fl ·1 1.1'[ •H 1 •1 .-.,,, • .r h1· 1,1 1 ,, ,. ···"' , . , • 1, ,, 1, 11 1111 .1, 11 jj' Uiiwl:Jt1l;:.1'.;;i.!::l1 ~1;::.~:L; :t:;;:J11;!!;11~~Jr~· - + ~ .,~-~-1~li!ttf$!: ~~+.!i4U4·d:~ r· iir.+ .. i, ·1 '.\, ii1{1f! Ii.~ i:tt, ,,,. ;, ,.,. l'" ilj' ,, "" "" 1P• I''··· 'if' 'fl 'll"fi. l . I rr· 'Iµ ·rt :m ·'It. ·1 'I''"" ,., .. !fit, d· . I dh i·"I' I Hr· I' I !Ht"""" y, 11· 1· H., •ii• ~: ,. j •1.• Ii 1, r •tr• 1· · 1· ·I' t · · ! t· ·I r ! it•: r '• t11· ·rl! •·1 ·1 1 • • It ,.., · • ·11 rj~ • 1 ·1 • • $! :r:;I! 11!: ::r: :!!! ti!; iql ;::: ~ :: Ir illi 11 i ti 11:1 i I ·f ' : i,I ii;) fri :H!~:i: di! ;if; ii:1 ';!: :!i! 'fl, '! iH1 !,1 1 I 1ih !r· iPl Htl i1i : tll + l ' :~:~t111· :;,: :i:; 1;1, 1111: '''I [II. : :: 'T jJ·i 'J' FU 111 1 t 1 11 il ili' 'It· i!li i::, 'Ir I'll' 1pr 1lri iii' till ·111~ 11 . it t ''1n11 ~ :1t. 11\i !I t ~'1 'l'.1!'! 1,:i:,,,, .. , ..... Ii q.,1.r, 1.,,. ·' ,.11111 1!11 1 ! 1 ·! 1nl1 !l1J1·111 '1' • 11 •1!111111··i rP ··11·! • 111· 1111 '''' ·111·1 i ~:t:i~:i.~ :.l..1.!.i-:..:;..· :l.'.·h~. !...:..~; :L~ ·~; :i '~I.,~ ., 11· . I • , .11 ..... .:li·di!illitif ~.Ll ,ii; ff~ I j . 1 • ! ltttt'. mt . .1-: !T-1... ~·ti 11•· ··!I" 1:1• ., 1·1"1i··. ,; rri; I '1 I ' r 11 "r-i-· IT'~ ttl fT!TIThl.~ nil ,r-r, tr! ji ,_ m I I I I 11 Ir' II T •• ~. r' 1 ••1 •• ' 'f 1 I~ ,, 1 ·• . t ·r· T 1 ' • • . +11 l i-H ! 11" .• 1' r 1 "I' . II 1 • 1 ! ' I"' :ltr!i[!ik ;Ii' ;:i: dil:1 i;· 1J1·: . :! 111·lrm ffljd,J' ; 11  Ii ii lili nrl rw pj1 ogri d1i )!:! rftt f·11 ! ql .n101111 11! !qi l: 1 40 h .. , ... ,, . ..,. ·' ... ,11 .,,,, ·, ,,1. ... ,, •. " l'h" . 11 J i • 1 , 1ll' , .. 1 · 4 ,,. 1 1 1~n:1 ,· 11,1 r t 1 1, rn· ·" , , H, 1· i" 1• 11 ..... ,,., ·.·" ... ,,, ·11· ... 1. ;. .. 11· 1··· .... '.' :+.11111t·. . f . i .. I. 1· 1·. iH' ,. I , ,11·f1·1'1·1~·, ,1 'f1 ·1. . •. I ml Hl"ll' id 1· . I , t, ..... "'' .,.,' ' '''I .; t I 'I' ,. 'I ~I 1trf I f I l r I " Tl I 11 I cl "'I" ' I[ t Ii I I 'l I I ,,. :·, ·i•· "'.~lliJj_ ii; ,.r. ,~ : 11 · :· ·; · 11~; · r r · J i · 11 - ;, I J: :1 J:i..w1 ; I l I , , · ' ' I· 1 ,1-11 
;; r 81!::1!/!ll :rr 1 ·'.~ i ,;:: ::.1 :::=· !Ji rt:H' ~ r • t 1 - t II I! f i, "Hr l [ 1·1 i ;H1 1ti' I I n t r . ' . '1 .. r ::~ :•fi u::o~i :11dr:i lt!: :11: i:i 1:1! ,+rdiP r . · l , 1ffl tfrl lffi !lit I , lfr,!111 ::f ml Ud rrl I.' rn l U I , 11, 1J l 
:.·1"i'i!:tj:f:;:h!ii:;;H" jfi!lltitftµPii !UJrt1it. t 11j1i .j,fl) rrlB1·t' f'i[ITI1n1111ii ';1j I 1! I r[i 1·1 1'.f · .,11 ·tn,,, 1ff1 r.r •H; !J ·1 J4"-t lf·1 rl·t il1' !ti 1-li-it r . II 1 1 t ITil H-;, i_r; \-i-tlH~· 'it !-!• ·r - + , 1 
:,11:ii!1 1'." ~!· 1 ;[!: '.;: i\11 !fl·;\!! fi mr1~w l+', a'([ f /~~·· rf 'i~illi:tt HJ ti 1 , , till 'II •. ,. , . ., it,!., •. I"' "" • 1JI I Ir rm IHI ctr I ' fl ~· I ' titil+H\ ' l l'tl ' t t1 I t1·1· H+! •f-d ·r·· •rr• r'r, •·t 1 •·•! 7· t .. f-t-· :-' '"'t ' .:-i- -;· i•' 1 1 · • ' .· ., ' 20 f- · 20 II;• 111: ,,, ''Ii '""'' I''' fl I It! '"' o!f·lti lrJ rl20 H+. j l1ll!H\!Di! I'" ff hi 11·2q,I: I li•1 •jf·1m ' .. I c!l 1 t I• i ff " Tffll !ti! 1[ri~j 1fr1:'"E'.i @pit 1:1! nHt:i . ' 1 1~ L, Ht . ; I ' ' fi ·fil g ifl: ill!1:f\l i L1ri!; j':+! i 1111 11 i It I .. ' 1 \H' . l :im hm. 'rp' T tt•lft mt~i I . t :lli~tll ill# I r l ~!j im "'··.ffii!·\ti!1l·!il11Ti [TT1 ~rl l:•jll"t ;t ·1 fl l tl1 .r ii!!ilfi i:Jl i1l1 iif!ir iirliU', hf! i:rl 1!1dllr11fl r ;i1, '"+ JI . ! r lH11~;L r,H !Iii :1l1 Iii: i!:iilliJ ::!1,1d 1ni e11: 1:1~ ii ·1H, t i Ir 1iif,I+1111 I 
:-::.,:.·11tt:"""·'·;:11.;·,· :~•,:,, 11ii :,1fl'Jn'1'iif,J ,.1 .1 ,n ,,111:p 1 i1" 11j1t1; 111:i:n111·:r1111:1W1r+ii1r1111 1 ·1·1·1 11111· i1 1.n!1,~ iJJ·I I ',.,, I'> 1,,, tl,I ... 111·" filmil .1.11 I "t' I 'I' Ii I" 11i' If ' I Ir r 1m'11' !!I\ u lli'l 'llr ·111 pr. I I Ir,. 11[111.i,f~. ·  111 . ,. t ·1 I I 1 j I 11 I • r' tj••H•• ... •Htj rr1• f' 1 1 14 ' ~ . 1 w•·r 't•11 r-•1.,J)Mµ·1~· II .. H ,tr.1'" . r . t;:· j:r 1, !Jlt i.;: ' p t1q I I !'11tITti t{ lht Hm 1n I I j t ' •' t j ! . n u -;' t 1·n id a·I fiil rm; T 1lf1 :n1 1 1:~ rn l i~ ·-! : ti1 .. i I . 1·:1. '11'1r.:I: !lif: 111· 1'1'1""1' ll, itcl ii:, i.1'· 1:1 Ir:. ,11Jtm1 fr r:r "i,IH l 1·1, ,11. i .. l ~JI 1:1·1@ ,1,, im r, 1 •.• 1 ;1·11· lfl111· lt·1: .;ii:,.,,· 111· ·11·11 ·,1 J ,ttl n, i i , !tt . 0 t f hh ' 1: 'II 1. H. hi , ! I •I ••• II' It tH Ht • I • ,1. I f', u' . ; . )', 111 ••. .,: "· 1 • lt~I 11 1 I !I ? ' IL . !Jl I 
AOOO 3500 3000 (CM') 2500 2000 1800 1600 1400 1200 1000 (CM') BOO 60( 





13 Abraham, R.; Loftus, P. "Proton and C NMR Spectroscopy", 
Heyden and Son, Philadelphia, 1978. 
2. Allerhand, A.; Doddrell, D.; Komoroske, R. J. Chem. Phys., 
1971, 22. 189. 
3. Arjunan, P.; Shymasundar, N.; Berlin, K. D.; Najjar, D.; Rackley, 
M. G. J. Org. Chem. 1981, 46, 626-629. 
4. Augustin, J.; Hasselbach, W. Eur. J. Biochem., 1973, ~. 114-121. 
5. Beddard, G. S.; West, M.A. "Fluorescent Probes", Academic Press, 
New York, 1981. 
6. Bernstein, E. Ber., 1883, 1&_, 2609. 
7~ Birdsall, N.; Lee, A.; Levine, Y.; Metcalfe, J.; Partington, P.; 
Roberts, G. J. Chem. Soc. Chem. Commun., 1973, 757. 
8. Bradley, R. A. in "Modern Fluorescence Spectroscopy", Vol. II 
Wehry, E. L. (ed.); Plenum Press, New York, 1976, Chapter 3. 
9. Branton, D. Proc. Natl. Acad. Sci., 1966, 22• 1048-1056. 
10. Breitmfiier, E.; Spohn,.K.; Berger, S. Angew. Chem. Internat. Edit., 
1975, 1-!!:_, 144. 
11. Brocklehurst, J. R.; Freedman, R. B.; Hancock, D. J.; Radda, G. K. 
Biochem. J., 1970, 116, 621. 
12. Brown, H. C.; Lane, C. F. J. Am. Chem. Soc., !.2.ZQ, 92, 6660. 
13. Cadenhead, D. A.; Kellner, B. M. J.; Jacobson, K.; Papahadjopoulos, 
D. Biochemistry, !.221., J&., 5386-5392. 
14. Carlack, E. A.; Mossetig, E. J. Am. Chem. Soc., 1945, ~. 2255. 
15. Caspar, M. L.; Stothers, J. B.; Wilson, N. K. Can. J. Chem., 
1975, _g, 1958. 
16. Caswell, A.H.; Hutchison, J. D. Biochem. Biophys. Res. Commun., 
1971, 42, 43-49. 
17. Caswell, A.H.; Warren, S. Biochem. Biophys. Res. Commun., 1972, 
46, 1757-1763. 
87 
18. Doddrell, D.; Allerhand, A. J. Am. Chem. Soc., 1971, _21, 1558. 
19. Doddrell, D.; Glushko, V.; Allerhand, A. J. Chem. Phys., 1972, 
3683. 
20. Faucon, J.; Lussan, C. Biochim. Biophys. Acta, 1973, 307, 
454-466. 
21. Fox, C. F. Scientific American, 1972, 226, 30-38. 
22. Golden, R.; Stock, L. M. J. Am. Chem. Soc.,~. _2±," 3081. 
23. Gray, G. R. Varian Instrument Applications, 1982, ~. 11-12. 
88 
24. Harrison, R.; Lunt, G. G. "Biological Membranes - Their 
Structure and Function", John Wiley and Sons, New York, 1975. 
25. Iljinsky, M. A.; Gindin, L. G.; Kasakova, V. A. C. R. Acad. Sci. 
URSS, 1938, 20, 555. 
26. Jacobs, R. E.; Oldfield, E. Progress in NMR Spectroscopy, 1981, 
_!±, 113. 
27. Janiak, M. J.; Small, D. M.; Shipley, G. G. Biochemistry, .!21.§., 
..!2_, 4575. 
28. Jasaitis, A. A.; Kuliene, V. V.; Skulachev, V. P. Biochim. 
Biophys. Acta, 1971, 234, 177-181. 
29. Johns, S.; Leslie, D.; Willing, R.; Bishop, D. Aust. J. Chem., 
1977' 30, 813. 
30. Johns, S.; Leslie, D.; Willing, R.; Bishop, D. Aust. J. Chem., 
1977' 30, 827. 
31. Johns, S.; Willing, R. Chem. Phys. Lipids, l222• 24, 11. 
32. Jost, P.; Waggoner, A. S.; Griffith, 0. H. in "Structure and 
Function of Biological Membranes'.', Rothfield, L. I. (ed.); 
Academic Press, New York, 1971, Chapter 3. 
33; Kimura, K.; Takahashi, M.; Tanaka, A. Chem. Pharm. Bull. (Tokyo), 
1960, ~. 1059. 
34. Laarhoven, W. H.; Cuppen, Th. J. H. M.; Nivard, R. J. F. Tetra-
hedron, 1970, ~' 4865. 
35. Levine, Y. K.; Birdsall, N. J.M.; Lee, A. G.; Metcalfe, J. C. 
Biochemistry, 1972, _!_!_, 1416. 
36. Levy, G. C. J. Chem. Soc. Chem. Commun., 1972, 352. 
37. Levy, G. C. Acc. Chem. Res., !211_, &_, 161. 
89 
38. Levy, G. C.; Cargroli, J.; Anet, F. J. Am. Chem. Soc., !1Zl• 22_, 
1527. 
39. Levy, G. C.; Komoroski, R.; Halstead, J. J. Am. Chem. Soc., 1974, 
2.§_, 5456. 
40. Levy, G. C.; Lichter, R.; Nelson, G. 11 l3c Nuclear Magnetic 
Resonance Spectroscopy", 2nd ed., Wiley and Sons, New York, 
1980. 
41. Marcinkiewicz, J.; Zeierzykowski, W.; Murawski, R. Chem. Stosow., 
1972, ~' 297. Chem. Abstr., 1973, ~' 57688v. 
42. McGrath, A. E.; Morgan, C. G.; Radda, G. K. Biochim. Biophys. 
Acta, 1976, 426, 173-185. 
43. Najjar, D. Ph.D. Dissertation, Oklahoma State University, 1981. 
44. Overath, P.; Trauble, H. Biochemistry, 1973, ~. 2625-2634. 
45. Podo, F.; Blasie, J. K. Proc. Natl. Acad. Sci., 1977, J.!±., 
1032-1036. 
46. Rabi, I.; Ramsey, N.; Schwinger, J. Rev. Mod. Phys., 1954, 26 
167. 
47. Reed, W.; Politi, M. J.; Fendler, J. H. J. Am. Chem. Soc., !2§1_, 
103, 4591-4593. 
48. Robinson, J. D.; Birdsall, N. J.M.; Lee, A. G.; Metcalfe, J. C. 
Biochemistry, 1972, _!_!_, 2903-2909. 
49. Russell, J. C.; Costa, S. B.; Seiders, R. P.; Whitten, D. G. 
J, Am. Chem. Soc., 1980, 102, 5679-5680. 
SO. "Sadtler Standard C-13 Nuclear Magnetic Resonance Spectra", 
Sadtler Research Labs, Philadelphia. 
51. Schuldiner, S.; Rottenberg, H.; Avron, M. Eur. J. Biochem., 1972, 
ll· 64-70. 
52. Singer, S. J.; Nicholson, G. L. Science, 1972, 175, 720-731. 
53. Stewart, F. H. C. Aust. J. Chem., 1960, ll_, 478. 
54. Stoffel, w.; Michaelis, G. Ho:eEe-Seyler's z. Physiol. Chem., 
~. 357, 7-19. 
55. Stoffel, w. ; Michaelis, G. HoE:ee-Seyler's z. Physiol. Chem., 
~. 357, 21-33. 
56. Stiller, K.; Waiss, A. C.; Haddon, W. F. Chem. Ind. (London), 
1975, 652. 
57. Stothers, J. B. "Carbon-13 NMR Spectroscopy"~ Academic Press, 
New York, 1972, p. 98. 
58. Sunamoto, J.; Kondo, H.; Nomura, T.; Okamoto, H. J. Am. Chem. 
Soc., ~. 102, 1146-1152. 
59. Thulborn, K. R.; Sawyer, W. H. Biochim. Biophys. Acta, 1978, 
511, 125-140. 
60. Verkleij, A. J.; Ververgaert, P. Ann. Rev. Phys. Chem .. , 1975, 
1§_, 101. 
90 
61. Wallach, D. F. H.; Ferber, E.; Selin, D.; Weidekarnm, E.; Fischer, 
H. Biochim. Biophys. Acta, 1970, 203, 67-76. 
62. Willard, H. H.; Merritt, L. L.; Dean, J. A. "Instrumental 
Methods of Analysis", D. Van Nostrand Co.; New York, 1974. 
PART II 





The discovery of the identity and biological importance of vitamin 
A or retinol (1) was the result of many research efforts during the 
early part of this century. In 1909-1911, a fat-soluble extract from 
egg yolk, fat-soluble A or vitamin A as it was later named, was found 
to be essential for life. 48 , 49 Between 1928 and 1930, the relationship 
between vitamin A and the carotenoid pigments, such as $-carotene (~), 
. 10 20 33 




purified, and determined the structural formula for vitamin A. 11 •24 •25 
. h . h 1 . .d . 1 (3)36,37,51,52 Since t at time, two ot er natura retinoi s, retina _ 





Although the structures of vitamin A and its derivatives were not 
determined until the early 1930's to mid 1940's, the biological impor-
tance of these substances has long been recognized. Egyptian documents 
dating back to about 1500 B.C. describe the use of liver, which has a 
high vitamin A content, as a treatment for night blindness. 40 Early 
sailors suffering from night blindness also found that eating fish 
liver restored their 1 . . 34 norma vision. As early as 1925, the importance 
of retinal in the maintenance and differentiation of epithelial tissue 
16 
was known. In 1935, Wald demonstrated that retinal was vital to the 
9 10 
vision cycle. ' In 1946, Arens and co-workers found that retinoic 
1 
acid was important in the promotion of growth. Figure 1 shows the 
biological importance and interconversions of the natural retinoids, 








Figure 1. Biological Importance and Interconversions of Natural Retinoids 
2 34 
Vitamin A deficiency causes a multitude of health problems ' 
including night blindness and xerophthalmia. In xerophthalmia, one of 
the first histological changes observed is the keratinization of the 
55 
cornea and conjunctiva of the eye. Untreated, this condition leads 
ultimately to blindness. Another result of vitamin A deficiency is 
the abnormal keratinization of the epithelia of the lungs, trachea, 
k . . . 1 d . 2' 34 s in, gastrointestina tract, an urinary tract. For example, in 
1 h 1 . h l" 34 . f 1 1 rats, norma trac ea epit e ium consists o a regu ar, co umnar 
arrangement of cells, all of which have cilia pointing into the lumen. 
After three weeks of vitamin A deficiency, crowding and disarrangement 
of the epithelial cells is observed, and the cilia are missing in many 
34 
places. After four weeks, an area of metaplasia consisting of 
34 superimposed, stratified cells is seen. After five weeks of vitamin 
94 
A d f . . 1 . . b d 34 e iciency, squamous metap asia is o serve . Flattened, strat.ified 
cells have replaced the original columnar arrangement of epithelial 
cells, and sheets of keratin can be seen peeling off into the lumen. 
Although vitamin A deficiency causes many health problems, an 
excess of retinal or the other natural retinoids is also harmful. 
Hypervitaminosis A, the condition resulting from excessive intake of 
vitamin A or its derivatives, produces a variety of symptoms depending 
upon the amount of retinoid ingested and the length of time it is used 
in excess. Acute toxic effects resulting from a single large dose of 
a retinoid include drowsiness, irritability, headache, increased intra-
2 
cranial pressure, and vomiting. Chronic toxic effects resulting 
from the ingestion of large doses of a retinoid for long periods of time 
include faulty formation of keratin in epithelial tissue, thickening of 
h k . f . d f f h b d h h . z, 34 t e s in, so tening an ractures o t e ones, an emorr aging. 
During pregnancy, large doses of vitamin A and other retinoids cause 
• 
95 
birth defects such as cleft palate, exencephaly, and skeletal anomalies. 
Many dermatological diseases, including acne, psoriasis, and 
ichthyoses, are the results of changes in epithelial keratinization. 
The abnormal keratinization found in these skin disorders and in 
certain precancerous conditions is similar to that found in vitamin 
A def iciency. Since vitamin A and its derivatives are important in 
the normal maintenance and differentiation of epithelial tissue, 
natural and synthetic retinoids have been investigated for use in the 
prevention and treatment of skin disorders and cancer. 
Retinoids in the Treatment of Skin Disorders 
Two recent books present an overview of some of the most recent 
d . h f d 1 . 1 d. . . .d 39,45 a vances in t e treatment o ermato ogica iseases using ret1no1 s, 
In 1941, Peck and co-workers reported the use of vitamin A in the 
. . 41 
treatment of Darier's disease. In 1951, Porter described the effects 
f 1 b ·1 . 43 o retina on pityriasis ru ra pi aris. trans-Retinoic acid in a 
mixture of ethanol and ethylene glycol effectively clears acne vulgaris 
26 
after 4-6 weeks for mild cases and after 2-3 months for severe ones. 
The retinoid is applied for long periods of time at a concentration 
(0.05-0.25 weight %) such that noticeable irritation of the skin occurs. 
Topical application of retinal is also reported to be effective in 
the treatment of acne. 50 At concentrations between 0.05 and 1 weight% 
in 95% ethanol or propylene glycol, this retinoid is at least 50% 
effective. Retinal has the advantage over trans-retinoic acid in that 
it does not produce irritation or inflammation of the skin. Retinal is 
also effective in the treatment of actinic and nonactinic keratosis. 57 
Several synthetic retinoids have been studied for use in the 
treatment of dermatological diseases. For example, 13-cis-retinoic 
acid (~) is useful in the treatment of severe or "therapy resistant" 
acne. 23 , 42 This retinoid is given orally in doses ranging from 0.05 
to 2.0 mg/kg body weight. Within 12 weeks, almost all lesions dis-
appear, and few lesions recur after 80 weeks. The C22 analog of 
retinoic acid, namely 6 and its Na+ and K+ salts, has proven useful 
5 6 
in the treatment of seborrheic and ichthyosiform dermatoses. 29 Two 
desmethyl analogs of retinoic acid 7 and 8 have proven more valuable 
7 8 
than either retinal or retinoic acid for the healing of wounds. 28 The 
retinoid 7 has also been effective in the treatment of psoriasis and 
96 
acne. The aromatic retinoid 9 was of value in the treatment of various 
. . 15 22 types of psoriasis. ' 
97 
9 
Retinoids in the Prevention and Treatment 
of Cancer 
In 1926, the relationship between vitamin A deficiency and cancer 
was reported by Fujimaki. 13 In the study, rats that were fed a vitamin 
A deficient diet developed carcinomas of the stomach. Since that time 
other researchers have reported similarities between vitamin A deficient 
epithelial tissue and certain precancerous lesions. For example, the 
addition of retinoids can reverse the anaplastic epithelial lesions 
induced in prostate glands by chemical carcinogens. 7 •27 In another 
study, the a?ministration of retinyl palmitate prevented the formation 
of tracheal tumors in hamsters that were treated with the carcinogen, 
benzo[a]pyrene, and iron oxide. 44 More recently, Bollag demonstrated 
that skin papillomas induced by 7,12-dimethylbenzo[a]anthracene and 
croton oil regressed when treated with trans-retinoic acid. 3 •4 
Although many of these early studies indicated that natural 
retinoids were potentially useful in the prevention and treatment of 
certain forms of cancer, they also demonstrated that the natural 
. 'd h d d" . d' d 40 ret1no1 s a two istinct isa vantages. First of all, with the 
exception of trans-retinoic acid which is not stored in the body, 
natural retinoids are stored in the liver. Even after a massive dose 
98 
of these compounds, the retinoid level in the blood does not increase 
proportionately. Thus, in vivo it is difficult to obtain an adequate 
distribution of natural retinoids within the body and, more importantly, 
at specific target sites within the body. The second disadvantage of 
the natural retinoids is the toxicity related to high doses. This 
toxicity, hypervitaminosis A, distinctly limits the clinical.use of 
natural retinoids. 
In an effort to overcome the disadvantages of the natural retinoids, 
a variety of synthetic retinoids have been prepared and tested for use 
in the prevention and treatment of cancer. Two methods are commonly 
employed to examine the activity of these new retinoids. In the first, 
papillomas of the skin are induced in mice using 7,12-dimethylbenzan-
h h . . . d ·1 h 30 t racene as t e initiator an croton oi as t e promoter. After 
multiple papillomas (with an average diameter of 3 mm) have developed, 
the experimental retinoid is applied intraperitoneally at days 1 and 
8 as a suspension or solution in arachis oil. On day 14, the average 
sum of the papilloma diameters is measured and compared to the corres-
ponding initial value. In conjunction with the antipapilloma activity 
studies, the retinoids are tested for toxicity. The experimental 
substance in arachis oil is injected intraperitoneally into mice for 
a 14 day period. The results of these two tests are expressed as a 
therapeutic ratio. .This ratio is the quotient of the effective dose 
resulting in 50% regression of papillomas in two weeks and the minimum 
daily dose that causes hypervitaminosis A during the same length of 
time. 
The second method used to determine the pharmacological activity 
of synthetic retinoids was developed by Sporn and co-workers for use at 
99 
the National Cancer Institute. 38 This procedure determines the in 
vitro ability of an agent to reverse keratinization in tracheal organ 
cultures from vitamin A deficient hamsters. The tracheas are cultured 
in a serum-free medium and are gassed with 50% o2 , 45% N2 , and 5% COz. 
After 3 days in the retinoid-free medium, some of the tracheas are 
harvested and examined. In general, most of the specimens examined 
have significant squamous metaplasia. The remaining cultures are 
divided into two groups. The first one is treated with the experimental 
retinoid in spectrograde DMSO. The second set of cultures is treated 
with an equivalent amount of DMSO. The culture medium is changed 3 
times a week for the next 10 days. At that time, all of the tracheas 
are harvested, fixed in 10% buffered formalin, and embedded in paraffin. 
Cross-sections of the tracheas are then examined under a microscope for 
the presence of keratin and keratohyaline granules. In 90% of the 
control cultures, both keratin and keratohyaline granules are seen. A 
synthetic retinoid is judged to be active if neither keratin nor kera-
tohyaline granules are seen or if only keratohyaline granules are not 
present. If both are seen, the retinoid is considered to be inactive. 
All of the synthetic retinoids reported result from modifications 
of the hydrocarbon ring, hydrocarbon side chain, or polar terminal 
group of vitamin A (Figure 2). One of the earliest modifications of 
. . 17 19 56 
retinal was the preparation of the corresponding methyl ether 10. ' ' 
This retinoid was found to be as active as retinal in supporting growth 
in rats and less toxic than retinal when given in large doses. Other 
synthetic retinoids in which the terminal polar group of retinal has 
been modified are 11-14. Retinoid 11 is reported to be active in the 
hamster tracheal organ culture and relatively nontoxic to tracheal 
100 
·1 47 carti age. Retinoids 12-14 have been assayed using the same method. 
At 10-8 M, 12-14 are 20%, 33.3%, and 80% active, respectively. This 



















Figure 2. Regions of the Vitamin A Molecule. 
Several retinoids (15-18) in which the carboxyl group of retinoic 






17 R=NH-@-o2c(cnHZn+l), n=l-18 
18 
50% reversal of keratinization occurs in the hamster tracheal organ 
culture (ED5 0) is 5 x 10-lO M for 12., and 2 x 10-9 M for 16. 46 The 
retinoids ll are reported to show low systemic toxicity and adequate 
specificity for epithelial cancer sites. 14 The retinoid 18 is 100% 
-9 active in the tracheal organ culture at 10 M while trans-retinoic 
acid is 88.4% active at the same concentration. 54 
Another large group of retinoids that have been synthesized and 
38 assayed are those in which the. hydrocarbon ring of trans-retinoic 
acid has been modified. The structures and En50 1 s for some of these 
compounds are shown in Table I. 
Retinoids in which the hydrocarbon side chain of retinal or 
retinoic acid has been modified are not as common. Assays using the 
38 
tracheal organ culture have been reported for ~ and 20. The c22 
101 
analog § has 
an ED50 of 3 
an ED50 of 3 x 10-
9 M while 13-cis-retinoic acid (12) has 
-11 
x 10 M. 
A number of retinoids involving several modifications of retinol 
have also been synthesized and assayed. Some of these are shown in 
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TABLE I 
STRUCTURE AND ACTIVITY OF RING-MODIFIED RETINOIDs38 
R 
R 
Hamster Tracheal Organ Culture 
ED50 (M) 
cX 7 x 10-10 
OH 
Qr 7 x 10-10 
0 





0 -8 >l x 10 s 
(Q( 
N 
3 x 10-7 
((a 2 x 10-9 
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19 6 
Tables II and III. The arotinoid 20 and its corresponding acid ~ 
38 
have also been assayed using the hamster tracheal organ culture. The 
-11 
ED50 values for both compounds were 1 x 10 M. 
20 
21 
Although a large variety of synthetic retinoids have been prepared 
and tested for use in the prevention and treatment of epithelial cancer, 
only a few of these compounds (19, 20, and 21) have been shown activity - - -
comparable to that of trans-retinoic acid (ED50 = 3 x 10-ll M). 13-cis-
Retinoic acid is currently used clinically in the treatment of acne, but 
it has not been approved for the prevention or treatment of cancer. The 
two aromatic retinoids, or "arotinoids" 20 and 21, have shown promising 
activity in both common assays. These two compounds, however, are 
hundreds of times more toxic than retinoic acid. Further research in 
104 
TABLE II 
· STRUCTURE AND ACTIVITY OF RETINOIDS WITH MULTIPLE MODIFICATIONS30 
Hypervitaminosis A Papilloma Effect 
Structure 
Dose (mg/kg) Dose (mg/kg) % Change 
12.5 12.5 -48 
3 3 -52 
0.75 o. 75 -44 
C02C2H5 
200 200 -34 
0.2 0.05 -48 
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TABLE III 

























the modification of natural retinoids is needed before synthetic 
retinoids will be clinically useful in the prevention and treatment 
of epithelial cancer. 
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CHAPTER II 
RESULTS AND DISCUSSION 
Although a vast number of modified retinoids have been synthe-
sized and assayed for use in the prevention and treatment of cancer, 
few of these vitamin A derivatives are clinically useful due to the 
toxic effects associated with hypervitaminosis A. Ideally a modified 
retinoid suitable for clinical use should be at least as active and 
less toxic than trans-retinoic acid. Two aromatic retinoids (" arotinoids") 
20 and 21 which have approximately the same activity as trans-retinoic 
acid in the hamster tracheal organ culture assay are hundreds of times 
. h . . "d 38 more toxic t an trans-ret1no1c ac1 . In order for these "arotinoids" 
to be clinically useful, structural modifications must be made such 
that the activity is maintained and the toxicity is reduced. Reported 
herein are the syntheses and pharmacological activity of four "hetero-
arotinoids" 22a-~ in which a heteroatom has been incorporated into 
the arotinoid molecule. 




Synthesis of Heteroarotinoids 
The synthetic routes used to prepare 22a and 22b from 23-32 are 
shown in Figures 3-5. The final step used to form the C-C double bond 
of the heteroarotinoid molecule involved a Wittig reaction using an 
appropriate phosphonium salt 32 and ethyl 4-formylbenzoate (33). The 
acid 22c was prepared (73.4%) by saponification of the corresponding 
ester 22b. The sulfoxide ~was obtained (44.7%) by treatment of the 









The sulfide 22a was prepared by a Wittig reaction between the phos-
phonium salt 32a and ethyl 4-formylbenzoate (33). The phosphonium salt 
32a was obtained in several steps beginning with thiophenol. Two 
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nBuLi hexane, ether 
oHc-Q-co2c2H5 (33) 
ether 
Synthesis of Heteroarotinoids 22a and 22b 
111 
In the best procedure, sodium thiophenoxide and l-bromo-3-methyl-2-
butene (24) were heated in acetone for 24 h to give 3-methyl-1-
(phenylthio)-2-butene (28) in a yield of 83.4%. Cyclization of 28 
using P2o5 and 85% H3Po4 in refluxing benzene gave 4,4-dimethylthio-
chroman (29a) (75.8%). In the second method, ethyl 3-(phenylthio)-
propionate (26a) was prepared (82.5%) by treatment of thiophenol (23) 
with ethyl acrylate in the presence of a catalytic amount of sodium 
112 
ethoxide. A Grignard reaction using methylmagnesium chloride with 26a 
gave 2-methyl-4-(phenylthio)-2-butanol (27a, 80.1%). Cyclization of 
27a using P2o5 and 85% H3Po4 in refluxing benzene gave 4,4-dimethyl-
thiochroman (29a, 81.5%). 
4,4-Dimethylthiochroman (29a) was acetylated using acetyl chloride 
and stannic chloride in benzene at room temperature for 5 h. The only 
product isolated from this reaction was 4,4-dimethylthiochroman-6-yl 
methyl ketone (~). The absolute structure of 30a was determined by 
a single crystal X-ray diffraction analysis of the corresponding 
sulfone 30c. The sulfone 30c was prepared by treatment of the sulfide 
30a with 30% H2o2 in glacial acetic acid at room temperature for 72 h. 
30a 30% Hz02/CH3COzH> 




The ketone ~was reduced to the corresponding alcohol ~ (94%, 
crude) by treatment with LiAlH4 in ether. The desired phosphonium 
salt ~ was prepared by treating 3la with triphenylphosphine hydro-
bromide in methanol at room temperature for 26 hours. A Wittig 
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reaction involving 32a and ethyl 4-formylbenzoate gave the desired hetero-
arotinoid 22a in which the C-C double bond had the _§_ configuration. 
The manner in which the configuration about the double bond was deter-
mined will be discussed later. 
The ether 22b was prepared by a Wittig reaction involving the 
phosphonium salt ~ and ethyl 4-formylbenzoate (33). Several methods 
6,8 An for the synthesis of the chroman ring system are available. 
alternate route was designed and used to prepare 4,4-dimethylchroman 
(29b). 3-Phenoxypropionic acid (25) was esterified using conventional 
techniques to give the corresponding methyl ester 26b. Treatment with 
methylmagnesium chloride gave 2-methyl-4-phenoxy-2-butanol (27b, 76.4%). 
Cyclization of 27b using anhydrous aluminum chloride in nitromethane 
at room temperature gave~ (62%). 
4,4-Dimethylchroman (29b) was acetylated by treatment with acetyl 
chloride and aluminum chloride in nitromethane. Only one of the four 
possible regioisomers was isolated. Using the splitting patterns of the 
1 aromatic protons in the H NMR spectrum, the regioisomer isolated must 
be either the 6- or 7-acetyl isomer (~or 30b'). Of these two, the 
6-acetyl isomer 30b was expected since the directing influence of 
oxygen is normally greater than that of carbon. Based upon this expec-
tation and the fact that acetylation of 4,4-dimethylthiochroman (29a) 
gave the 6-acetyl isomer, the regioisomer isolated in the acetylation 
of ~ should be 1Qp. 
3 COCH 3 OO-cocH3 2 
10h 30b' 
The ketone lQE was reduced to the corresponding alcohol (59.4%) 
using LiAlH4 . The phosphonium salt 32b was prepared (80.3%) by 
treatment of 3lb with triphenylphosphine hydrobromide in methanol at 
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room temperature for 24 hours. The reaction time used in the prepara-
tion of 32b was very important. When a reaction time of 48 hours was 
used, a mixture of products was obtained. 1H NMR spectral data indi-
cated that ring opening may have occurred during the longer reaction 
time. 
A Wittig reaction involving the phosphonium salt ill and ethyl 4-
formylbenzoate (33) gave the desired heteroarotinoid ~· Purification 
of 22b was achieved with difficulty. The yellow oil obtained initially 
was chromatographed on neutral alumina using 5% ether/hexane. 1H NMR 
spectral data of the resulting oil indicated the presence of not only 
the desired heteroarotinoid 22b but also a small amount (% 18%) of the 
corresponding Z isomer, 34. The E isomer 22b was obtained in pure form 
by recrystallization from 95% c2H50H with cooling to o0 c and scratching 
to induce crystallization. The Z isomer 34 was not isolated. 
Ethyl 4-formyl benzoate (33), which was used in the Wittig 
reactions, was obtained in three steps (Figure 6) from E_-toluic acid 
(35). The acid (35) was esterified using conventional techniques to 
give the corresponding ethyl ester 36 (75%). Oxidation of 36 at 0-5°C 
35 
6, 36 h 
H2so4 , H20 








Figure 6. Preparation of Ethyl 4-Formylbenzoate. 
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using Cro3 in the presence of H2so4 , acetic anhydride, and acetic acid 
gave the diacetate 37 (55.6%). Hydrolysis of 37 using H2so4 , ethanol, 
and water gave the corresponding aldehyde 33 (50.9%). 
Initially, a shorter synthetic route to the heteroarotinoids 22a 
and 22b was considered. In this route, the C-C double bonds of 22a 
and 22b were to be formed with Wittig reactions involving the ketones 
30a and 30b and the phosphonium salt 38. Ketones 30a and 30b were 
prepared using the methods discussed earlier. The phosphonium salt 
38 was synthesized in two steps from a-bromo-.E_-toluic acid (39). 
Acid 39 was treated with H2so4 in refluxing ethanol for 70 minutes to 
give a mixture of products. The major product (~ 90%) obtained was 
the desired bromoester 40. The minor product (~ 10%) obtained was the 
ester 41. These compounds were not separated. Treatment of the crude 
mixture containing 40 and 41 with triphenylphosphine in refluxing 
benzene for 18 hours gave the desired phosphonium salt 38 (84.3%). 
30a X=S 
30b X=O 38 
A Wittig reaction involving phosphonium salt 38 and ketone 
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30a was attempted. Treatment of a solution of 38 in DMSO with NaH at 
room temperature gave the corresponding ylid as indicated by the bright 
orange color. A solution of the ketone 30a in DMSO was added, and the 
resulting mixture was stirred at room temperature for 12 hours. 
Work-up gave an orange-brown oil. IR spectral data indicated the 
presence of unreacted 30a. The reaction was repeated using·benzene 
instead of DMSO. After the ketone 30a was added to the red-brown 
solution containing the ylid, the mixture was heated at reflux for 
72 hours. Work-up gave an orange-brown oil. IR spectral data again 
indicated the presence of a large amount of unreacted 30a. 
A modified Wittig reaction using the phosphonate 42 and the 
ketone 30a was attempted. The phosphonate 42 was prepared from a-
bromo-.E_-toluic acid (39). Esterification of 39 using H2so4 in 
CH 30 2C~H2f <OC2Hs>2 
0 
42 
refluxing methanol for 75 minutes gave the corresponding methyl ester 
43 (75%). The ester 43 was treated with triethyl phosphite at reflux 
for 1 hour. A mixture of the resulting crude phosphonate 42 and the 
ketone 30a was treated with NaOCH3 in refluxing methanol for 18 hours. 
Work-up gave a yellow oil which contained a large amount of unreacted 
ketone ~ as indicated by IR spectral data. Since the ketone 30a 
appeared to be unreactive in a Wittig reaction, it was converted to 
the phosphonium salt 32a. The phosphonium salt 32a was then used 
successfully in a Wittig reaction with ethyl 4-formylbenzoate as 
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described earlier 
NMR Analysis of the Heteroarotinoids 
1 
The H NMR spectral data for the heteroarotinoids ~-22d are 
shown in the Experimental Section. The 13c NMR spectral data for 
22a-22d are shown in Table IV. In general, the assignments for the 
aliphatic carbons and protons were made by comparison to the appro-
priate precursors. The assignments for the aromatic protons in the 
chroman and thiochroman rings were based upon the observed splitting 
patterns. The assignments for the protonated aromatic and vinylic 
carbons were made using heteronuclear correlated 2-dimensional (HETCOR. 
2-D) NMR. 
Although the assignments for the aliphatic protons of the hetero-
arotinoids 22a-~ were straightforward in most cases, the assignments 
for H(2) and H(3) of the sulfoxide 22d were not as obvious. These 
assignments were made using a heteronuclear correlated 2-dimensional 
(HETCOR 2-D) NMR experiment. A contour plot of the resulting 2-D 
spectrum is shown in Figure 7. 
1 
A HETCOR 2-D NMR experiment can be used to correlate the H NMR 
chemical shift of a particular set of protons with the 13c NMR chemical 
h "f f h d" b 16 s i t o t e correspon ing car on. In order to utilize the infor-
1 13 
mation contained in a 2-D or contour plot, either the H or C NMR 
spectrum must be assigned unequivocally. 
13 
For ~' the . C NMR spectrum 
in the aliphatic region was assigned easily using INEPT experiments. 35 
A comparison of the contour plot of the HETCOR 2-D NMR experiment, the 
13 
C NMR spectrum in the region between approximately 12 and 45 ppm, and 
1 the H NMR spectrum between approximately o 1.0 and 3.6 allowed the 
TABLE IV 
13c NMR DATA FOR THE HETEROAROTINOIDS 
12 
18 20 21 22 
C0 2CH 2 CH 3 
17 ~
3 15 R 
8 















15(19) 128. 9 . 
16(18) 129.4a-
20 166. 5 ./ 
Nonprotonated 143.0 
Aromatic and 141.7 











































































assignments for H(2) and H(3) to be made easily. Further information 
concerning the use of HETCOR 2-D NMR experiments can be found in Part 
I, Chapter II. In 22d, the multiplet at c 1.84-1.94 (1 H) was assigned 
to H(3) while the multiplet at 6 2.48-2.62 (1 H) was assigned to H(3) . 
a e 
The multiplet at 6 3.06-3.25 (2 H) was assigned to H(2) and H(2) . 
a e 
The assignments for the aromatic protons, H(5), H(7), and H(8), of 
the chroman and thiochroman rings in 22a-22d were made using the observed 
splitting patterns. In the heteroarotinoids, H(5) was expected to give a 
doublet with J = 2-3 Hz. In~' H(5) actually gave a broad singlet while 
in 22b-22d H(5) gave a doublet with J = 3 Hz. H(7) was expected to give 
a doublet of doublets with J = 2-3, 7-10 Hz. In~' H(7) actually gave 
a multiplet while in 22b-22d H(7) gave the expected doublet of doublets 
with J = 3, 9 Hz. · H(8) was expected to give a doublet with J = 7-10 Hz. 
In ~-22d, H(8) gave the expected doublet with J = 9 Hz. 
The 13c NMR assignments for the protonated aromatic and olefinic 
carbons of 22a, 22b, and 22d (Table IV) were made using HETCOR 2-D NMR 
experiments in the aromatic region. The results of these experiments 
are shown in Figures 8-10; ·Similar assignments for 22c were made by 
comparison to 22b. 
1 . 
The H NMR chemical shifts of the vinylic protons and vinylic 
methyl groups in ~-22d were used to tentatively assign the conf igur-
ations of the C-C double bonds in these modified retinoids. In 22a-22d, 
the vinylic proton gave a singlet at 6 6.82, 6.77, 6.80, and 6.86, 
respectively. In the !-arotinoids 20, 21, 44, and 45, the vinylic 
proton gave a singlet at 6 6.85, 6.88, 6.72, and 6.82, respectively, 
while the Z-arotinoid 46 gave a singlet at 6 6.46. In the heteroaro-
tinoids ~-22d, the vinylic methyl group gave a singlet at o 2.28, 
122 
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Figure 8. Contour Plot of HETCOR 2-D Spectrum of 22a in the Aromatic 
Region 
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Contour Plot of HETCOR 2-D Spectrum of 22d in the Aromatic 
Region """"" 
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2.27, 2.31, and 2.30, respectively. In the ~-arotinoids 20, 21, 44, and 
45, the corresponding signals were observed at o 2.30, 2.37, 2.27, and 
2.28, respectively, while in the ~-arotinoid 46, a signal at 8 2.23 was 
observed. A comparison of these data indicated that the heteroaroti-







X-Ray Diffraction Analysis of 30c 
A single crystal X-ray diffraction analysis of the sulfone 30c was 
performed by Dr. E. M. Holt to verify the identity of the regioisomer 




in Figure 11, the results of the analysis indicated that 32:::, was acetyl-
ated in the 6-position. The important bond angles and bond distances 
are shown in Table V. 
X-Ray Diffraction Analysis of Heteroarotinoid ~ 
The preliminary results of a single crystal X-ray diffraction 
analysis of the heteroarotinoid 22a are shown in Figure 12. Two modifi-
cations of 22a were found in the crystal exam1ned. In both of these, 
the C-C double bond had the E-configuration as predicted using 1H NMR 
spectral data. Further data is needed before a comparison of the con-
formation of this heteroarotinoid to that of other retinoids can be 
made. Examination of the degree of planarity between the two aromatic 
rings and comparison to other retinoid systems would be very interesting. 
Pharmacological Activity of the Heteroarotinoids 
The pharmacological activity of the heterotinoids 22a-22d was 
assessed at.the Illinois Institute of Technology Research Institute 
. h h d d 1 d b s d k 38 d" d . using t e met o eve ope y porn an co-war ers as iscusse in 
Chapter I. In this assay, the in vitro ability of 22a-ill to reverse 
keratinization in vitamin A deficient hamster tracheal organ cultures 
was determined. A retinoid was considered to be active if neither 
keratin nor keratohyaline granules were seen or if only keratohyalin 
granules were not present. If both were seen, the retinoid was con-
sidered to be inactive. 
The preliminary assays of ~. 22b, and 22d have been completed. 
The results for these heteroarotinoids are summarized in Table VI. The 
assay of the acid 22c is currently in progress. A comparison of the 
127 
Figure ll. St · ructure of Ketone 30c .. ,,, .... 
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TABLE V 
BOND ANGLES AND DISTANCES OF 19.f 
Angle Angle (0 ) Bond 
Bond 
Distance (~) 
01-Sl-02 117.4(2) Sl-01 . 1. 443 (3) 
Ol-Sl-C2 109.3(2) Sl-02 1. 447 (4) 
01-Sl-C8' 109.3(2) Sl-C2 1. 761 (4) 
02-Sl-C2 110.1(2) Sl-C8' 1.767(3) 
02-Sl-C8' 107.3(2) C2-C3 1.539(5) 
C2-Sl-C8' 102.2(2) C3-C4 1.535(5) 
Sl-C2-C3 107.7(2) C4-C9 1.548(5) 
C2-C3-C4 113.5(4) C4-Cl0 1.546(6) 
C3-C4-C9 106.3(3) C4-C4' 1.537(4) 
C3-C4-Cl0 110.3(3) C4'-C5 1.397(4) 
C3-C4-C4' 112.3(3) C5-C6 1.394(5) 
C9-C4-C4' 110.4(2) C6-Cll 1. 501 (4) 
Cl0-C4-C4' 107.4(3) C6-C7 1.399(5) 
C4-C4'-C5 118.9(3) C7-C8 1.374(4) 
C4-C4'C8' 124.4(2) C8-C8' 1.409(5) 
C5-C4'-C8' 116.7(3) Cll-Cl2 1.505(6) 
C6-C5-C4' 121. 8(3) Cll-03 1.227(5) 
C5-C6-C7 120.1 (3) 
C5-Et6-Cll 121.7(3) 
C6-C6-Cll 118. 2 (3) 












Figure 12. Structure o ·noid 22a. f Heteroaroti ~ 
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TABLE VI 
ACTIVITY OF THE HETEROAROTINOIDS IN THE HAMSTER TRACHEAL ORGAN CULTURE 
Retinoid Concentration (M) % Active ED5o (M) 
trans-retinoic acida 10-10 76.9 
10-ll 41. 7 
10-12 23.1 









22d 10-8 71. 4 'V 3 x 10-10 
10-9 71. 4 
10-10 28.6 
aThe activity of trans-retinoic acid was determined for each set of 
experiments. 
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ED50 values for ~' 22b, and 22d with the ED50 value for the standard, 
trans-retinoic acid, indicates that all three of the heteroarotinoids 
are active. The activities of the sulfide 22a and the ether 22b are 
very high although slightly less than those of the standard, trans-
retinoic acid, and the arotinoids 20 and 21 (En50 = 1 x 10-ll M). 37 
The activity of the sulfoxide 22d is approximately one order of magni-
tude lower than that of the sulfide 22a. 
The initial purpose of this work was to modify the basic arotinoid 
structure in such a way as to maintain the high degree of activity of 
the arotinoids while simultaneously reducing the associated toxicity. 
The incorporation of the heteroatoms, S and O, into the basic arotinoid 
structure appears to meet the first objective. The heteroarotinoids 
22a and 22b show a high degree of activity. At this time, toxicity 
studies of 22a-~ have not been performed. It is, therefore, not 
possible to determine whether the incorporation of a heteroatom such 
as S or 0 effectively reduces the toxicity associated with the arotinoid 
molecules. 
Suggestions for Future Work 
Toxicity studies of the heteroarotinoids 22a-~ must be performed 
to determine what effect, if any, the heteroatom has on the overall 
toxicity of the retinoids. If the toxicity studies are promising, a 
variety of modifications can be made on the heteroarotinoid structure 
to improve the activity and reduce the toxicity. Modifications which 
could prove useful include: (1) the incorporation of other heteratoms 
such as Nor P (22e, 22f), (2) expansion or contraction of the hetero-
atom-containing ring (47, 48), (3) changes in the side chain to give 
132 
the heteroretinoids such as 49, (4) changes in the terminal polar group 
to include the corresponding acids, alcohols, amides, aldehydes, and 
ethers, and (5) the incorporation of two heteroatoms into the aroti-
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Reactions were carried out under a nitrogen atmosphere when 
necessary. All reactions were stirred using a magnetic stirrer unless 
otherwise specified. During work-up, solvents were removed using a 
rotary evaporator unless otherwise stated. NMR spectral data were 
obtained using either a Varian XL-100 (15) NMR spectrometer equipped 
with a Nicolet TT-100 PFT accessory or a Varian XL-300 NMR spectrometer. 
All NMR data were reported in ppm or o values downfield from TMS using 
either TMS or CDCl3 as an internal reference. IR spectral data were 
obtained using a Perkin-Elmer 681 IR spectrophotometer. Melting points 
were determi~ed using a Thomas Hoover melting point apparatus and were 
uncorrected. 13c NMR spectral data for some compounds have been in-
eluded in Chapter II. 
Starting Materials 
The following starting materials and special reagents were pur-
chased from the source listed and were used without further purification: 
thiophenol (Aldrich, bp 169°c), ethyl acrylate (Aldrich, bp 99°C), 
l-bromo-3-methyl-2-butene (Columbia, bp 50-S2°C/SO mm), acetyl chloride 
0 (Fisher, bp 49-50 C), methylmagnesium chloride/THF (2.9 M, Aldrich), 
12_-toluic acid (Aldrich, mp 180-182°C), a-bromo-12_-toluic acid (Aldrich, 
134 
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mp 223-227°c), stannic chloride (Baker), aluminum chloride (Fisher), 
and 3-phenoxypropionic acid (Columbia, mp 97-98°C). Anhydrous solvents 
were obtained as discussed below. Ether and thiophene-free benzene 
were distilled from sodium prior to use. All other solvents were used 
without purification. 
Ethyl 3-(Phenylthio)propiopate (26a) 
Freshly distilled ethyl acrylate (75 mL) was added dropwise under 
N2 to a stirred, ice-cold mixture of thiophenol (23, 31.5 g, 0.286 mol) 
and sodium ethoxide (1.0 g) in a 250-mL round bottom flask. The ice 
bath was removed, and the mixture was stirred at RT for 24 h. The 
mixture was diluted with ether (30 mL) and filtered. The ether and 
excess ethyl acrylate were removed (vacuum). Vacuum distillation gave 
49.6 g (82.5%) of 26a as a colorless liquid: bp 115-118/0.2 mm (lit. 21 
117°C/2.5 mm); IR (neat) 1730-1750 cm-l (C=O); 1H NMR (CDC13) o 1.22 
(t, 3 H, OCH2C_!!3), 2.58 (t, 2 H, C_!!2co2c2H5), 3.14 (t, 2 H, Se_!!2), 4.1 
13 (q, 2 H, OC_!!2CH3), 7.07-7.37 (m, 5 H, Ar-H); C NMR (CDC13) ppm 171.3 
[C(l)], 135.2, 129.8, 128.8, 126.3, 60.5 [C(a)], 34.4 [C(2)], 29.0 
[C(3)], 14.2 [C(6)]. 
2-Methyl-4-(phenylthio)-2-butanol (27a) 
A solution of ethyl 3-(phenylthio)propionate (26a, 20.0 g, 0.0952 
mol) in dry ether (5 mL) was added under N2 to a stirred solution of 
methylmagnesium chloride in THF (2.9 M, 105 mL, 0.3045 mol) in a 300-mL 
round bottom flask equipped with a condenser at a rate such that the 
solution boiled. The solution was then heated at reflux for an addi-
tional 36 h. The mixture was cooled to RT and quenched with saturated 
aqueous NH4Cl. The supernatant liquid was decanted, and the residue 
was washed with dry ether (3 x 50 mL). The combined organics were 
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dried (Na2so4), and the ether was removed (vacuum). Vacuum distilla-
tion of the crude oil gave 14.95 g (80.1%) of 27a as a colorless 
liquid: bp 93-98°C/O. 01 mm (lit. 32 l 10-1139 C/O. 7 mm); IR (neat) 
3200-3600 cm-l (OH); 1H NMR (CDC13) 8 1.17 S, 6 H, [(C_!!.3) 2] ,·1.66-1.84 
[m, 2 H, ArSCH2C.!!_2 J, 2.38-2.47 [br s, 1 H, 0.!!_], 2.88-3.05 [rn, 2 H, 
ArSC.!!_2], 7.04-7.34 [m, 5 H, Ar-.!!_]; 13c NMR (CDC13) ppm 28.2 [C(4)J, 
28.9 [C(l)], 42.4 [C(3)], 70.2 [C(2)], 125.3 [C(4')], 128.2, 128.4 
[C(2'), C(3')], 136.1 [C(l')]. 
3-Methyl-l-(phenylthio)-2-butene (28) 9 , 12 
A mixture of thiophenol (23, 16.3 g, 0.148 mol) and NaOH (6.0 g, 
0.150 mol) in acetone (100 mL) was heated at reflux under N2 with 
vigorous stirring for 1 h in a 250-mL round bottom flask equipped with 
a condenser. A solution of l-bromo-3-methyl-2-butene (24, 22.3 g, 
0.1498 rnol) in acetone (20 mL) was then added dropwise. The resulting 
mixture was maintained at reflux for 24 h. The mixture was concen-
trated to 30 mL, diluted with H20 (75 mL), and extracted with ether 
(2 x 50 mL). The organic layers were combined and washed with 5% 
aqueous NaOH (3 x 30 mL), H20 (50 mL), and brine (50 mL). After drying 
(Na2so4) the solution, the solvent was removed to leave a pale yellow 
liquid. Vacuum distillation gave 22.0 g (83.4%) of 28 as a pale yellow 
liquid: bp 76-78°C/0.15 mm; 1H NMR (CDC13) 8 1.55 [s, 3 H, C.!!_3J, 1.68 
[s, 3 H, C.!!_3], 3.52 [d, 2 H, PhSC.!!_2], 5.24-5.34 [m, 1 H, (CH3) 2C=C.!!_J, 
13 7.1-7.36 [m, 5 H, Ar-.!!_]; C NMR (CDC13) ppm 136.7, 136.0, 129.4, 
128.4, 125.7, 119.2, 32.1, 25.6, 17.6. 
4,4-Dimethylthiochroman or 3,4-Dihydro-4,4-
dimethyl-2H-l-benzothiopyran (29a) 5 
Method I. A mixture of 2-methyl-4-(phenylthio)-2-butanol (~, 
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10_.o g, 0.0510 mol), H3Po4 (85%, 5 mL) and P2o5 (3 x 6.0 g, 0.1268 mol) 
in benzene (SO mL) was heated at reflux under N2 with vigorous stirring 
for 24 h in a 100-mL round bottom flask equipped with a condenser. The 
P2o5 was added in three equal portions at 6 to 8 h intervals. After 
cooling, the solution was decanted from the reddish-purple residue, 
and the residue was washed with ether (2 x 25 mL). The combined 
organics were washed with 5% aqueous NaHco3 (2 x 50 mL) and saturated 
aqueous NaCl (3 x 50 mL). After drying (Na2so4) the solution, the 
solvent was removed, and the residual oil was vacuum distilled to give 
7. 4 g (81. 5%) of ·~ as a colorless liquid: 
0 1 
bp 80-85 C/0.01 mm; H NMR 
(CDC13) o 1.29 [s, 6 H, (C}!3) 2], 1.84-1.97 [m, 2H, H(3)], 2.91-3.03 
13 [m, 2 H, H(2)], 6.9-7.35 [m, 4 H, Ar-_!!]; C NMR (CDC13) ppm 23.1 
[C(2)], 30.2 [C(4')], 32.9 [C(4)), 37.7 [C(3)], 123.8, 125.8, 126.26, 
126.3 [C(5),.C(6), C(7), C(8)], 131.5 [C(4a)], 141.7 [C(8a)]. 
Method II. A mixture of 3-methyl-l-(phenylthio)-2-butene (28, 
21.5 g, 0.1208 mol), H3Po4 (85%, 15 mL), and P2o5 (17.2 g, 0.1211 mol) 
in benzene (200 mL) was heated at reflux under N2 with vigorous stirring 
for 20 h in a 500-mL round bottom flask equipped with a condenser. 
After cooling, the supernatant liquid was decanted from the phosphorus-
containing residue, and the residue was washed with ether (3 x 50 mL). 
The organics were combined and washed with 5% NaHco3 (2 x 75 mL), H20 
(75 mL), and brine (2 x 75 mL). After drying (Na2so4) the solution, 
the solvent was evaporated leaving a yellow oil. Vacuum distillation 
gave 16.3 g (75.8%) of 29a as a pale yellow liquid: bp 80-85°c/O.Ol 
The spectral data obtained (1H and 13c NMR) were identical to mm. 
those obtained for 29a prepared by Method I. - . 




Stannic chloride (4. 7 mL, 0.0501 mol) was added dropwise under N2 
to a stirred solution of 4,4-dimethylthiochroman (29a, 6.6 g, 0.0371 
mol) and acetyl chloride (3.1 g, 0.0395 mol) in dry, thiophene-free 
benzene (30 mL) in a 100-mL, round bottom flask. The resulting dark 
green solution was stirred at RT for 5 h and then diluted with water 
(30 mL) and cone. HCl (15 mL). The resulting mixture was heated to 
just below the boiling point for 15 min. The mixture was allowed to 
cool to RT, and the two layers were separated. The aqueous layer was 
extracted with benzene (5 x 20 mL), and the combined organic layers 
were washed with H20 (2 x 50 mL), 5% aqueous Na2co3 (2 x 40 mL), H20 
(50 mL), and brine (60 mL). After drying (Na2so4) the solution, the 
solvent was removed (vacuum) leaving a viscous brown oil. Vacuum 
distillation gave 4.92 g (60.3%) of 1Q.§. as a pale yellow oil: bp 126-
o -1 1 
130 C/0.02 mm; IR (neat) 1675-1685 cm (C=O); H NMR (CDC13) 8 1.32 
[s, 6 H, (C!!_3 ) 2 J, 1.84-1.97 [m, 2 H, H(3)], 2.51 [s, 3 H, C!!_3C=O], 
2.95-3.07 [m, 2 H, H(2)], 7.07 [d, 1 H, J = 8 Hz, H(8)], 7.53 [dd, 1 H, 
13 
J = 2 Hz, H(7)], 7.95 [d, 1 H, J = 2 Hz, H(5)]; C NMR (CDC13) ppm 
23.1 [C(2)], 26.2 [C(lO)], 29.7 [C(4')], 32.9 [C(4)], 36.8 [C(3)], 125.7, 
126.1, 132.8, 139.3, 141.6, 196.7 [C(9)]; Mass spectral data for 
+ m/e (M ) 220.0922; Found: 220. 0922. 
4,4-Dimethylthiochroman-6-yl Methyl 
Ketone 1,1-Dioxide (30c) 
A solution of 30% H2o2 (13 mL) was added dropwise under N2 to a 
stirred solution of the sulfide ~ (0.5 g, 2.294 mmol) in glacial 
acetic acid (10 mL) in a 50-mL round bottom flask. The mixture was 
stirred at RT for 72 h during which time a white solid precipitated. 
The mixture was poured into ice water (25 mL). The resulting white 
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solid was filtered, washed with water (10 mL), and air dried. Recrys-
tallization (95% ethanol) gave 0.3 g (52.3%) of 2Q£ as white crystals: 
0 
mp 197-197.5 C; IR (KBr) 1680-1690 (C=O), 1280-1295 (802), 1130-1150 
-1 1 
cm (802); H NMR (CDC13) o 1.46 [s, 6 H, (C!!_3) 2J, 2.36-2.48 [m, 2 H, 
H(3)], 2.63 [s, 3 H, c_g_3C=O], 3.37-3.50 [m, 2 H, H(2)], 7.91-8.04 [m, 
13 
3 H, Ar-H]; C NMR (CDC13) ppm 26.8 [C(lO)], 30.6 [C(4')], 34.5 [C(4)], 
35.4 [C(3)], 47.0 [C(2)], 124.2, 126.9, 127.2, 139.8, 140.9, 145.1 
[Ar-_g_], 196.6 [C(9)]; Mass spectral data for c13H16o3s: 




+ m/e (M ) 
A solution of 4,4-dimethylthiochroman-6-yl methyl ketone (~, 4.0 
g, 0.0182 mol) in dry ether (20 mL) was added dropwise under N2 to a 
stirred suspension of LiAlH4 (1.0 g, 0.0264 mol) in ether (75 mL) in a 
250-mL round bottom flask equipped with a condenser. The resulting 
mixture was heated at reflux for 24 h. Ethyl acetate was then added 
dropwise to destroy the excess LiAlH4 . A solution of 5% HCl (50 mL) 
was added, and the mixture was stirred for 10 min. The layers were 
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separated, and the aqueous layer was extracted with ether (2 x 30 mL). 
The combined organic layers were washed with 5% aqueous Na2co4 (2 x 
50 mL) and brine (2 x 50 mL). After drying (Na2so4) the solution, the 
solvent was removed leaving 3.8 g (94% of ~as a colorless oil. 
Recrystallization (hexane) with cooling to o0 c gave a white granular 
powder: IR (melt) 3120-3640 cm-l (OH); 1H NMR (CDC13) o 1.3 [s, 6 H, 
(C.!!_3) 2], 1.39 [d, 3 H, c_g_3cHOH], 1.84-2.0 [m, 2 H, SCH2CH2J, 2.74-2.86 
[br s, 1 H, 0.!!_J , 2.9-3.06 [m, 2 H, SCH3], 4.71 [q, 1 H, CH3 C.!!_OH] , 
6.94-7.02 [m, · 2 H, Ar-.!!_] , 7.3-7.36 [m, 1 H, Ar-H] ; 13c NMR (CDC1 3) ppm 
142.0, 141. 6' 130.7, 126.6, 123.6, 123.2, 70.2 [C(9)], 37.7 [C(3)], 
'33.1 [C(4)], 30.2 [C(4')], 25.0 [C(lO)], 23.0 [C(2)]. 
[1-(4,4-Dimethylthiochroman-6-yl)ethyl]tri-




A solution of the alcohol ~ (0.5 g, 2.252 mmol) and triphenyl-
phosphine hydrobromide (0.78 g, 2.275 mmol) in CH30H (20 mL) was 
stirred at RT under N2 for 26 h in a 100-mL round bottom flask. Removal 
of the solvent left a yellow oil which solidified after repeated tri-
turation with dry ether. The resulting powder was stirred in dry ether 
(30 mL) for 8 h, filtered, and dried (110°C/2 mm) to give 0.9 g (73.1%) 
0 1 of 32a as a tan powder: mp 139-145 C (dee); H NMR (CDC13) o 1.07 
[s, 3 H, C.!!_3], 1.15 [s, 3 H, C.!!_3], 1. 75 [d, 3 H, CHC.!!_3], 1.80-1.88 
+ [m, 2 H, H(3)], 2.96-3.02 [m, 2 H, H(2)], 6.40-6.55 [m, 1 H, C.!!_P Ph3], 
6.58 [d, 1 H, H(7)], 6.86 [d, 1 H, H(8)], 7.45 [br s, 1 H, H(5)1, 
+ 7.62-7.90 [m, 15 H, P (c6_g_5) 3]. 
Ethyl (E)-p-[2-(4,4-Dimethylthiochroman-6-yl)-
propenyl]benzoate or Ethyl (E)-4-[2-(2,3-Di-
methyl-2H-l-benzothiopyran-6-yl)-l-pro-
penyl]benzoate (22a) 
A solution of _g_-butyllithium in hexane (1.55 M, 1.3 mL, 2.015 
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mmol) was added dropwise under N2 to a stirred suspension of the phos-
phonium salt~ (1.1 g, 2.011 mmol) in dry ether (30 mL) in a 100-mL, 
round bottom flask. The resulting dark red mixture was stirred for 
5 min. A solution of the freshly distilled aldehyde 33 (0.4 g, 2.247 
mmol) in dry ether (15 mL) was then added all at once. The mixture 
became creamy yellow and then cream-colored, and a large amount of 
off-white solid precipitated. After stirring at RT for 36 h, the 
mixture was filtered. The solid was washed with ether (50 mL). The 
combined filtrates were concentrated to give a yellow oil which was 
dissolved in warm 95% ethanol (50 mL). The resulting solution was 
filtered and then concentrated to 10 mL. After cooling slowly to RT, 
the resulting solid was filtered and washed with cold 95% ethanol. 
After drying in the air, 0.30 g (40.7%) of 22a was obtained as a white 
0 -1 1 
solid: mp 92-93 C; IR (KBR) 1710-1725 cm (C=O); H NMR (CDC13) o 
1.38 [s, 6 H, (C.!!_3) 2J, 1.41 [t, 3 H, OCH2c_g_3J, 1.96-2.02 [m, 2 H, 
SCH2c_g_2 J, 2.28 [s, 3 H, CH=C-C!:!_3], 3.04-3.09 [m, 2 H, SC!:!_2J, 4.4 [q, 
2 H, OC!:!_2]' 6.82 [s, 1 H, C=C!:!_], 7.11 [d, 1 H, H(8)], 7.21-7.28 [m, 
1 H, H(7)], 7.44 [d, 2 H, Ar-H], 7.54 [s, 1 H, H(5)], 8.07 [d, 2 H, 
+ m/e (M) 366.1653; Found 
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366.1650. An experiment using NaH/DMSO gave 33a (33.6%). 
Ethyl (E)-p-[2-(4,4-IJimethylthiochroman-1-oxo-
6-yl)propenyl]benzoate or Ethyl (E)-4-[2-(3,4-
Dihydro-4,4-dimethyl-2H-1-benzothiopyran-1-
oxo-6-yl)-l-propenyl]benzoate (22d) . ~ 
A solution of Naro4 (0.14 g, 0.654 mmol) in H20 (1 mL) was added 
in one portion under N2 to a stirred suspension of 22a (0.118 g, 0.322 
mmol) in methanol (10 mL) in a 100-rnL round bottom flask. The mixture 
was stirred at RT for an additional 36 h. A large amount of white 
solid precipitated during this time. The mixture was concentrated. 
The residue was dissolved in CHC13 (20 mL) and then filtered and con-
centrated. The resulting oil was triturated with cold hexane to induce 
crystallization. Recrystallization (hexane) gave 55 mg (44.7%) of~ 
as a white powder: mp 91-93°C; IR (KBr) 1700-1715 (C=O), 1030-1040 
-1 1 
cm (S-+O); H NMR (CDC13) cS 1.37 [s, 3 H, C.!!_3], 1.41 [t, 3 H, OCH2CH3J, 
1.51 [s, 3 H, C.!!_3], 1.84-1.94 [m, 1 H, H(3)], 2.30 [s, 3 H, CH=C(C.!!_3)], 
2.48-2.60 [m, 1 H, H(3)], 3.08-3.23 [m, 2 H, H(2)], 4.41 [q, 2 H, 
OCH2CH3 J, 6.86 [s, 1 H, C.!!_=C(CH3)], 7.46 [d, 2 H, Ar-.!!_], 7.51 [dd, J = 
9 ,Hz, J 3 Hz, 1 H, H(7)]; 7.58 [d, J = 3 Hz, 1 H, H(5)], 7.77 [d, J = 
9 Hz, 1 H, H(8)], 8.09 [d, 2 H, Ar-.!!_]; Mass spectral data for c23H26o3s: 
+ m/e (M) 382.1603; Found 382.1595. 
Methyl 3-Pherioxypropionate (26b) 
A solution of 3-phenoxypropionic acid (25, 10.0 g, 0.0602 mol) and 
PTSA (0.6 g) in methanol (250 mL) was heated at reflux through 3 A 
molecular sieve for 36 h under N2 in a 500-mL round bottom flask equipped 
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with a Soxhlet extractor and a condenser. The solution was allowed to 
cool to RT. The solution was then concentrated to a volume of 50 mL, 
diluted with water (50 mL), and extracted with ether (2 x 75 mL). The 
combined organic layers were washed with 5% aqueous NaHco3 (75 mL), 
H2o (75 mL), and brine (75 mL). After drying (Na2so4) the solution, 
the solvent was removed (vacuum). Vacuum distillation gave ·9.45 g 
(87.1%) of 26b as a colorless liquid: bp 85-87°C/O.l mm (lit. 52 109-
1120C/3 mm); IR (neat) 1740-1750 cm-l (C=O); 1H NMR (CDC13) o 2.78 
. 13 
(t, 2 H, C!!_2CH2CH3), 3. 70 (s, 3 H, OC!!_3), 4.23 (t, C NMR (CDC13) ppm 
34.3 [C(2)], 51. 7 [C(a)], 63.2 [C(3)], 114.5 [C(2')], 120.8 [C(4')], 
129.2 [C(3')], 158.3 [C(l')], 171.1 [C(l)]. 
2-Methyl-4-phenoxy-2-butanol (27b) 
A solution of methyl 3-phenoxypropionate (26b, 7.0 g, 0.0389 mol) 
in dry ether (20 mL) was added dropwise under N2 to a stirred solution 
of CH3MgCl in THF (2.9 M, 40.2 mL, 0.1166 mol) in a 200-mL round bottom 
flask equipped with a condenser. The mixture was heated at reflux for 
24 h, allowed to cool to RT, and quenched with saturated aqueous NH4Cl. 
The supernatant liquid was decanted, and the residue was washed with 
dry ether (3 x· 50 mL). The combined organic solutions were dried 
(Na2so4), and the solvent was removed. Vacuum distillation gave 5.35 
(76.4%) of 27b a colorless liquid: 0 (neat) as bp 81-84 C/0.07 mm; IR 
-1 
(OH); 1H NMR 3140-3620 cm (CDC13) 0 1. 26 s, 6 H, ( C.!!_3) 2 ' 
1. 95 (t, 
2 H, Ar0CH2C!!_2), 2.8-3.0 (br s, 1 H, 0!!_), 4.12 (t, 2 H, Ar0C!!_2), 6.82-
6.96 (m, 3 H, Ar-!!_), 7.16-7.3 (m, 2 H, Ar-.!!_); 13c NMR (CDC13) ppm 29.5 
[C(l)J, 41.6 [C(3)], 64.9 [C(4)], 70.3 [C(2)J, 114.3 [C(Z')J, 120.8 




A solution of 2-methyl-4-phenoxy-2-butanol (~, 7.8 g, 0.0433 
mol) in nitromethane (SO mL) was added dropwise under N2 to a stirred 
suspension of anhydrous AlC13 (7. 8 g, 0. OS84 mol) in nitromethane (30 
mL) in a 200-mL round bottom flask. After stirring at RT for an 
additional 24 h, a solution of 6 M HCl (80 mL) was added slowly. The 
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resulting mixture was stirred for 10 min and diluted with ether (SO mL). 
The layers were separated, and the organic layer was washed with H20 
(SO mL), saturated aqueous NaHco3 (4 x SO mL), H2o (SO mL), and brine 
(4 x SO mL). After drying (Na2so4) the solution, the solvent was 
removed. Vacuum distillation of the resulting dark brown oil gave 4.35 
g (62%) of 29b as a colorless liquid: bp 74-80°C/0. 7 mm (lit. 8 
0 1 93 C/10 mm); H NMR (CDC13) 8 1.31 [s, 6 H, (C.!:!_3) 2J, 1.80-1.84 [m, 2 H, 
13 
H(3)], 4.16-4.20 [m, 2 H, H(2)], 6.78-7.29 [m, 4 H, Ar-.!:!_]; C NMR 
(CDC13) ppm 30.5 [C(4)], 31.1 [C(4')], 37.7 [C(3)], 63.0 [C(2)], 116.9 
[C(8)], 120.4, 126.9, 127.0, 131.6. [C(4a)], 153.5 [C(Sa)]. 
4,4-Dimethylchroman-6-yl Methyl Ketone or 1-
(3,4-Dihydro-4,4~dimethyl-2H-l-benzopyran-
-6-yl)ethanone (30b) 
Anhydrous A1Cl3 (3.4 g, 0.02S5 mol) was added in small portions to 
a solution of 4,4-dimethylchroman (~, 4.0 g, 0.0247 mol) and acetyl 
chloride (2.0 g, 0.02S5 mol) in CH3No2 (35 mL) under N2 in a 100-mL, 
round bottom flask. . After stirring at RT fo:t 6 h, 6 M HCl (3S 
mL) was added slowly, and the resulting mixture was stirred for 10 min. 
The mixture was diluted with ether (40 mL), and the layers were separated 
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The organic layer was washed with H2o (40 mL), saturated aqueous NaHco3 
(4 x 30 mL), H2o (40 mL), and brine (2 x 40 mL). After drying (Na2so4) 
the solution, the solvent was removed leaving a dark reddish brown oil. 
Vacuum distillation gave 3.4 g (67.5%) of 30b as a pale yellow liquid: 
. . 0 -1 1 
bp 108-112 C/0.01 mm; IR (neat) 1675-1685 cm (C=O); H NMR (CDC13) o 
1.36 [s, 6 H, (C!!3) 2J, 1.83-1.87 [m, 2 H, H(3)], 2.55 [s, 3 H, C!!3C=O], 
4.24-4.28 [m, 2 H, H(2)], 6.83 [d, J 9 Hz , 1 H, H ( 8) ] , 7 . 71 [ dd , J = 
13 9 Hz, J = 3 Hz, 1 H, H{7)], 7.98 [d, J 3 Hz, H(5)]; C NMR (CDC13,) 
ppm 26.3 [C(lO)], 30.6 [C(4)], 30.7 [C(4')], 37.0 [C(3)], 63.4 [C(2)], 
116.9 [C(8)], 127.8, 128.16 [C(5), C(7)], 130.0, 131.6 [C(4a), C(6)], 
158.0 [C(8a)]; Mass spectral data for c 13H16o2 : m/e (M+) 204.1150; 




A solution of the ketone 30b (3.0 g, 0.0147 mol) in anhydrous 
ether (15 mL) was added dropwise under N2 to a stirred suspension of 
LiAlH4 (0.8 g, 0.0211 mol) in dry ether (50 inL) in a 200-mL round 
bottom flask equipped with a condenser. The mixture was heated at 
reflux for 24 h. After cooling to RT, ethyl acetate was added dropwise 
to destroy the excess LiAlH4. A solution of 5% HCl (50 mL) was then 
added, and the resulting mixture was stirred for 5 min. The layers 
were separated, and the aqueous layer was washed with ether (2 x 50 mL). 
The combined organic layers were washed with 5% aqueous Na2co3 (2 x 50 
mL) and brine (2 x 50 mL). After drying (Na2so4) the solution, the 
solvent was removed leaving a yellow oil which solidified after 
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scratching. Recrystallization (hexane) gave 1.8 g (59.4%) of 3lb as 
0 -1 1 
a white solid: mp 70-71 C; IR (KBr) 3140-3640 cm (OH); H NMR 
(CDC13) 8 1.31 [s, 6 H, (C.!!_3) 2], 1.43 [d, 3 H, CH3CHOH], 1.74-1.83 
[m, 2 H, H(3)], 2. 4-2. 44 [s, 1 H, 0.!!.l, 4.10-4.18 [m, 2 H, H(2)], 4. 76 
[ q , 1 H, CB.OH] , 6 . 7 6 [ d , J 9 Hz, 1 H, H(8)], 7.07 [dd, J = 9 Hz, 
13 
J = 3 Hz, 1 H, H(7)], 7.28 [d, J = 3 Hz, 1 H, H(5)], C NMR (CDC13) 
ppm 25.0 [C(lO)J, 30.6 [C(4)], 31.0 [C(4')], 37.6 [C(3)J, 63.0 [C(2)], 
70.2 [C(9)], 116.9 [C(8)], 124.0, 124.3 [C(5), C(7)], 131.4, 137.7 
[C(4a), C(6)], 152.9 [C(8a)]; Mass spectral data for c 13H18o2 : m/e 
(M+) 206.1307; Found 206.1308. 
[1-(4,4-Dimethylchroman-6-yl)ethyl]triphenyl-
phosphonium Bromide or [1-(3,4-Dihydro-4,4-
dimethyl-2H-l-benzopyran-6-yl)ethyl]tri-
phenylphosphonium Bromide (32b) 
A solution of the alcohol 3lb (0.7 g, 3.4 mmol) and triphenylphos-
phine hydrobromide (1.2 g, 3.5 Illlllol) in methanol (30 mL) was stirred 
under N2 at RT for 24 h in a 100-mL round bottom flask. The solvent 
was removed (vacuum), and the resulting oil was triturated repeatedly 
with dry ether until it solidified. The white solid was stirred in dry 
ether (30 mL) at RT under N2 for 4 h, filtered, and dried (ll0°c/~2 mm) 
to give 1.45 g (80.3%) of 32b as a white powder: mp 149-155°C (dee); 
lH NMR (CDC1 3) 8 1. 08 [s, 3 H, C.!!_3], 1.14 [s, 3 H, c_g_3J, 1. 72-1. 78 [m, 
2 H, H(3)], 1.83 [d, 3 H, CHC.!!_3], 4.12-4.18 '[m, 2 H, H(2)], 6.2-6.32 
+ -
[m, 1 R, C.!!.PPh3 , Br ] , 6.57 [d, 1 H, H(8)], 6.67 [d, 1 H, H(7)], 7.24 
+ [br s, 1 H, R(5)], 7.63-7.84 [m, 15 H, P (C6H5) 3]. 
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Ethyl (E)-p-[2-(4,4-Dimethylchroman-6-yl)pro-
penyl]benzoate or Ethyl (E)-4-[2-(3,4-Di-
hydro-4,4-dimethyl-2H-l-benzopyran-6-
yl)-1-propenyl]benzoate (22b) 
A solution of g_-butyllithium in hexane (1.55 M, 2.13 mL, 3.301 
mmol) was added dropwise under N2 to a stirred suspension of the phos-
phonium salt 32b (1. 75 g, 3. 296 mmol) in dry ether (30 mL) in a 100-mL 
round bottom flask. The resulting dark reddish brown mixture was 
stirred at RT for 5 min. A solution of. the aldehyde 33 (0.6 g, 3.371 
mmol) in dry ether (15 mL) was then added. The mixture changed from 
reddish brown to creamy yellow, and a large amount of off-white solid 
precipitated. After stirring at RT for 36 h, the mixture was filtered. 
The resulting solid was washed with ether (75 mL), and the combined 
filtrates were concentrated to give a yellow oil. The oil was chro-
matographed through a column (8 x 200 nm) packed with neutral alumi~a 
(about 10 g). The product was eluted with 5% ether/hexane (250 mL). 
Concentration of the eluent gave a viscous oil which was dissolved in 
a minimum amount of boiling 95% ethanol. Cooling the solution to o0 c 
and scratching gave 0.30 g (26.0%) of 119 as a white granular solid: 
0 -1 1 mp 72.5-73.5 C; IR (KBr) 1710-1725 cm (C=O); H NMR (CDC13) 8 1.37 
[s, 6 H, (C!!.3) 2J, 1.39 [t, 3 H, OCH2CB.3 J, 1.81-1.87 [m, 2 H, H(3)], 2.27 
[s, 3 H, CH=C(C!!.3)], 4.17-4.24 [m, 2 H, H(2)], 4.38 [q, 2 H, OC!!_2CH3 J, 
6.77 [s, 1 H, Cl!_=C(CH3)], 6.81 [d, J 9 Hz, 1 H, H(8)], 7.26 [dd, J = 
9 Hz, J = 3 Hz, 1 H, H(7)], 7.41 [d, 2 H, Ar=!!.], 7.44 [d, J = 3 Hz, 1 H, 
+ H(5)], 8.06 [d, 2 H, Ar-!!.]; Mass spectral data for c23H26o3 : m/e (M) 
350.1882; Found 350.1884. The presence of the Z isomer in the oil 
obtained from chromatography was indicated by the following 1H N}1R 
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signals: o 2.76-2.81 [m, H(3)], 2.20 [s, ~ C!!_=C(CH3)J, 4.16-4.20 
[m, H(2)], 6.44 [br s, ~ CH=C(CH3)J. 
(E)-p-[2-(4,4-Dimethylchroman-6-yl)propenyl]-
benzoic Acid or (E)-4-[2-(3,4-Dihydro-4,4-
dimethyl-2H-l-benzopyran-6-yl)-l-pro-
penyl]benzoic Acid (22c) 
The heteroarotinoid ~ (0.20 g, 0.571 mmol) was heated at reflux 
under N2 for 4 h in a solution of NaOH (0.1 g, 2.50 mmol) in 95% 
c2H50H (2 mL) and H2o (5 mL) in a 25-mL round bottom flask equipped 
with a condenser. After cooling slowly to RT, the solution was 
acidified (litmus) with cone. HCl. The resulting white solid was 
filtered, washed with water, and air-dried. Recrystallization (95% 
ethanol) gave 0.135 g (73.4%) of 22c as a white solid: mp 183-183.5°C; 
IR (KBr) 2390-3320 (OH, CH), 1670-1695 cm-l (C=O) ~ NMR (CDC13) o 
1.38 [s, 6 H, (CH3) 2J, 1.84-1.9 [m, 2 H, H(3)], 2.30 [s, 3 H, CH=C(CH3)J, 
4.21-4.26 [m, 2 H, H(2)], 6.80 [s, 1 H, C_!!=C(CH3)J, 6.83 [d, J = 9 Hz, 
1 H, H(8)], 7.29 [dd, J = 9 Hz, J = 3 Hz, 1 H, H(7)], 7.46 [d, J = 3 Hz, 
1 H, H(5)], 7.48 [d, 2 H, Ar-H], 8.15 [d, 2 H, Ar-!!); Mass spectral 
+ . 
data for c21H22o3 : m/e (M ) 322.1569; Found 322.1570. 
Ethyl 4-Formylbenzoate (33) 
A solution of ethyl J2_-toluate (36, 6.0 g, 0.0366 mol), glacial 
acetic acid (57 mL), and acetic anhydride (57 mL) in a 300-mL round 
bottom flask equipped with a thermometer and a mechanical stirrer was 
cooled to 0-5°c in an ice-salt bath. Cone. H2so4 (8.5 mL) was added 
slowly to the stirred solution. Chromium trioxide (10.0 g, 0.10 mol) 
was added in small portions over a period of 25 min. The temperature 
of the mixture was maintained below 5°c at all times. After stirring 
at 0-5°C for an additional 20 min, the mixture was poured into a 
100-mL beaker filled 2/3 full with ice. Cold water was then added 
to bring the total volume to 600 mL. The resulting dark green-brown 
mixture was extracted with ether (3 x 250 mL), and the orgariic layers 
were combined. The organic layer was washed with water (3 x 200 mL), 
5% aqueous Na2co3 (2 x 200 mL), and brine (200 ml). After drying 
(Na2so4) the solution, the solvent was removed leaving the diacetate 
37 as a pale yellow liquid. A mixture of the diacetate 37, cone. 
H2so4 (2 mL), water (20 mL), and 95% ethanol (20 mL) was heated at 
reflux under N2 for 45 min. in a 100-mL round bottom flask equipped 
with a condenser. The solution was allowed to cool to RT. After 
diluting the solution with water (40 mL), the resulting mixture was 
extracted with ether (3 x 40 mL). The combined organic layers were 
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washed with 5% aqueous NaHco3 (2 x 50 mL) and water (50 mL). After 
drying (Na2so4) the solution, the solvent was removed leaving a yellow 
liquid. Vacuum distillation gave 3.1 g (47.6%) of 33 as a colorless 
liquid: bp 80-84°C/0.05 mm (lit. 9 142-144 C/15 mm); IR (neat) 1705-1735 
-1 1 
cm (C=O); H NMR (CDC13) 0 1.42 (t, 3 H, OCH2CH3), 4.41 (q, 2 H, 
13 OC.!!_2CH3), 7.87~8.22 (pseudo q, 4 H, Ar-.!!_), 10.03 (br s, 1 H, C.!!_0); C 
NMR (CDC13) ppm 191.2 (.fHO), 165.2 (f_o2c2H5), 138.9, 135.2, 129.9, 
129.2 (Ar-f_), 61.4 (OCH2CH3), 14.2 (OCH2f.H3). 
Attempted Preparation of 22a 
A solution of the phosphonium salt 38 (1.0 g, 1.981 mmol) in dry 
DMSO (20 mL) was added rapidly under N2 to a 50% mineral oil dispersion 
of NaH (O.l g, 2.083 mmol) in a 100-mL round bottom flask. The 
resulting bright orange mixture was stirred for 5 min. A solution 
of the ketone ~ (0.44 g, 2.00 mmol) in DMSO (5 mL) was then added. 
Stirring was continued at RT for 12 h. The mixture was diluted with 
H2o (50 mL), acidified (litmus) with cone. HCl, and extracted with 
CH2c12 (4 x 20 .mL). The organic layer was washed with H2o (25 mL) 
and dried (Na2so4). The solution was concentrated to give an orange-
brown oil. IR spectral data indicated the presence of approximately 
150 
-1 
equivalent amounts of starting ketone 30a (1680-1690 cm ) and an ester 
-1 
(1715-1725 cm ). 
Attempted Preparation of 22a 
A solution of the phosphonium salt 38 (1.0 g, 1.981 mmol) in dry 
DMSO (10 mL) was added rapidly under N2 to a 50% mineral oil dispersion 
of NaH (O.l g, 2.083 mmol) in a 100-mL round bottom flask equipped with 
a condenser. The resulting bright orange mixture was stirred for 5 
min. A solution of the ketone 30a (0.44 g, 2.00 mmol) in dry benzene 
(50 mL) was then added. The resulting mixture was heated at reflux 
for 72 h. Water (40 mL) and cone. HCl (10 mL) were then added to the 
cooled solution. The layers were separated, and the organic layer was 
washed with H20 (30 mL) and brine (30 mL). After drying (Na2so4) the 
solution, the solvent was removed leaving an orange-brown oil. IR 
spectral data indicated the presence of approximately equivalent amounts 
-1 -1 
of starting ketone 30a (1680-1690 cm ) and an ester (1720-1730 cm ). 
Attempted Preparation of 22a 
A mixture of methyl a-bromo-.E_-toluate (43, 0.8 g, 3.495 mmol) and 
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triethyl phosphite (0.6 g, 3.614 mmol) was heated at reflux under N2 
for 1 h in a 10-mL round bottom flask equipped with a condenser. After 
cooling to RT, the solution was diluted with CH30H (5 mL) and ketone 
30a (0.77 g, 3.90 mmol). The resulting solution was added dropwise 
under N2 to a stirred solution of NaOCH3 (0.10 g, 3.518 mmol) in CH30H 
(17 mL). The solution was heated at reflux for 18 h. After cooling to 
RT, the solution was diluted with H20 (50 mL), and the pH was checked 
to ensure that the mixture was strongly basic (litmus). The mixture 
was extracted with ether (2 x 30 mL). After drying the (Na2so4) the 
organic layer, the so 1 vent was removed leaving a yellow oil. IR spec-
tral data indicated the presence of a large amount of unreacted ketone 
-1 30a (1680-1690 cm ). 
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13 C NMR Spectrum of 29b ............ 
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1 H NMR Spectrum of 3lb ,..,.,.. 
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IR Spectrum of 22b 
PLATE XXXVIII 
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IR Spectrum of 22c 
PLATE XXXIX 
ppm 180 160 11+0 120 . 100 80 60 1+0 20 0 13c 
+ 
, ,, ,,,,n~~-·~n---;rrf:"!T IJ[J]Jfil]-----!--02CH2CH3~ 
it! 
~i:i 
,lllllllmlllllllll"-Bul:mfllrimuml-·1•1=,, lfJ*1·00 ]!tti~t m -__ ::fn, __ ~-~~iifmlf~~--f-, 
1 H NMR Spectrum of 12._ 
PFT cw~; Solvent. . CDC1 3 . so. . 8S771 Hz; PW. • 1000 Hz; T •• 30 °C; Acq/SA. ' • 
Size. . K; P2/RF. . SS µs/dB; SF. . 100.lHz; FB. . 2 Hz; Lock. • 2H . D5/ST. . 2SO s ' f-' co 
co 
DC. . : Gated Off. . . Offset. . Hz; RF. . W/dB; NBW. . Hz . 
PLATE XX.XX 
ppm 180 160 140 120 . 100 80 60 4-0 
Till 
























+:R+1+H+1+i-iftfl+·. OOi11+Fmr -·-,..., .... 
PFT X CW : Solvent. 
Size. • 8 K; P2/RF. • 
1 
DC •• H Gated Off. 
W-4:-rm~~-~,, tt!:ll-tlSil+:;::t._ 
m-1-+l+_ r+=::i1{- ; ~- 3 r~ @:· _ -· rl.:.2T -. ·-= _ r . · .. - 1: itrc+-:tµ_· 4-1-++-W. 
. ,,r..,.,"1-:rL ... f,-r-'-' -c•·· t-t-Rf·=F , , , .,.,.,.c;=J•- H--rt-,t 




C NMR Spectrum of ~ 
CDC13 ; so .. 35101 Hz; PW •• 5000 Hz; T •• 30 °C; Acq/SA. • 600 
lOµs/dB; SF •• 25.2 Hz; FB.. Hz; Lock. 2H : D5/ST. . 5 





1. Arens, J. F.; van Dorp, D. A. Nature (London), 1946, 157, 190-
191. 
2. Berkow, R., Ed., "The Merck Manual", 13th ed., Merck and Co., 
Rahway, N.J., 1977, pp. 1151-1153. 
3. Bollag, W. Experientia, 1971, ]]__, 90-92. 
4. Bollag, W. Eur. J. Cancer, 1974, 10, 731-737. 
5. Brownbridge, P.; Warren, S. J. Chem. Soc. Perkins Trans. I, 1977, 
2272-2285. 
6. Butsugan, Y.; Tsukamoto, H.; Morita, N.; Bito, T. Chem Lett., 
1976, 523-524. 
7. Chopra, D. P.; Wilkoff, L. J. Proc. Am. Assoc. Cancer Res., 1975, 
16, 35. 
8. Colonge, J.; Le Sech, E.; Marey, R. Bull. Soc. Chim. France, 
195 7' 776- 779. 
9. Delisle, A. Annalen, 1890, 260, 250. 
10. Euler, .B. V.; Euler, H. V.; Karrer, P. Helv. Chim. Acta, 1929, 
Q, 278-285. Chem. Abstr., ill_2, Q, 3254. 
11. Euler, H. V.; Karrer, P. Helv. Chim. Acta, :!211-' 14, 1040-1044. 
12. Fleming, I.; Paterson, I.; Pearce, A. J. Chem. Soc. Perkins 
Trans. I, ~' 256-262. 
13. Fujimaki, Y. J. Cancer Res., 1926, 10, 469-477. 
14. Gander, R. J. Brit. UK Patent Appl. 2,026,493; February 6, 1980. 
Chem. Abstr., 1981, 94, 30960w. 
15. Gatti, J. C.; Cardama, J. E.; Gabrielli, M.; Cabrera, H. in 
"Retinoids: Advances in Basic Research and Therapy", Orfanos, 
C. E., et al. (Ed.); Springer-Verlag, New York, 1981, pp. 
185-192-. -
16. Gray, G. A. Varian Instrument Applications, 1982, 16, 11-12. 
190 
191 
17. Hanze, A. R.; Conger, T. W.; Wise, E. C.; Weisblat, D. I. J. Am. 
Chem. Soc., .!2!!:§, .IQ, 1253-1256. 
18. Hauptmann, S.; Brandes, F.; Brauer, E.; Gabler, W. J. Prakt. 
Chem., 1964, ~. 56-58. Chem. Abstr., ~' 61, 13225b. 
19. Isler, O.; Ronco, R.; Guex, W.; Hindley, N. C.; Huber, W.; Dialer, 
K.; Kofler, M. Helv. Chim. Acta, 1949, 32, 489-505. 
20. Isler, 0. in "Carotenoids", Isler, O., Ed., Birkhauser Verlag, 
Basel, 1971, pp. 11-27. 
21. Iwai, K.; Kosugi, H.; Miyazaki, A.; Uda, H. Syn. Commun. l21§, _§_, 
357-363. 
22. Jablonska, S.; Wolska, H.; Dabrowski, J.; Haftek, M.; Groniowska, 
M.; Jarzabek-Chorzelska, M. in "Retinoids" Advances in Basic 
Research and Therapy", Orfanos, C. E., et al. (Ed.); Springer-
Verlag, New York, 1981, pp. 165-173.-
23. Jones, D. H.; Cunliffe, W. J.; Cove, J. H. in "Retinoids: Ad-
vances in Basic Research and Therapy", Orfanos, C. E. , ~ al. 
(Ed.); Springer-Verlag, New York, 1981, pp. 255-258. 
24. Karrer, P.; Helfenstein, A.; Wehrli, H.; Wettstein, A. Helv. Chim. 
Acta, !21.Q, 11, 1084-1099. 
25. Karrer, P.; Morf, R.; Schopp, K. Helv. Chim. Acta, 1931, 14, 
1036-1040, 1431-1436. Chem. Abstr., 1932, ~. 4359. 
26. Kligman, A. M. U.S. Patent 3,729,568; April 24, 1973. 
27. Lasnitzki, I. Brit. J. Cancer, ~. 2_, 434-441. 
28. Lee, K. H. U.S. Patents 3,882,244; May 6, 1975; 3,966,967; June 
29, 1976. 
29. Lee, K. H. U.S. Patents 3,934,028; January 20, 1976; 4,021,573; 
May 3, 1977. 
30. Loeliger, P.; Bollag, W.; Mayer, H. Eur. J. Med. Chem.-Chim. Ther., 
1980, 15, 9-15. 
31. Lovey, A. J.; Fawson, B. A. J. Med. Chem., 1982, ~' 71-75. 
32. Montanari, F.; Daniel, R.; Hogeveen, H.; Maccagnani, G. Tetrahe-
dron Lett., 1964, 2685-2689. 
33. Moore, T. Biochem. J., 1930, 24, 692-702. 
34. Moore, T. "Vitamin A", Elsevier Publishing Co., New York, 1957. 
35. Morris, G. A.; Freeman, R. J. Am. Chem. Soc., 1979, 101, 760. 
36. Morton, R. A. Nature (London), ~' 153, 69-71. 
37. Morton, R. A.; Goodwin, T. W. Nature (London), 1944, 153, 405-
406. 
192 
38. Newton, D. L.; Henderson, W. R.; Sporn, M. B. Cancer Res., ~. 
40, 3413-3425. 
39. Orfanos, C. E.; Brawn-Falco, O.; Farber, E. M.; Grupper, C.; 
Polano, M. K.; Schuppli, R. "Retinoids: Advances in Basic 
Research and Therapy", Springer-Verlag, New York, · 1981. 
40. Pawson, B. A.; Ehmann, C. W.; Itri, L. M.; Sherman, M. I. J. Med. 
Chem., 1982, 25, 1269-1277. 
41. Peck, S. M.; Chargin, L.; Sobotka, H. Arch. Dermatol. Syphilol., 
1941, ~' 223-229. Chem. Abstr., 1941, 35, 2934. 
42. Plewig, G.; Wagner, A.; Nikolowski, J.; Landthaler, M. in 
"Retinoids: Advances in Basic Research and Therapy", 
Orfanos, C. E., et al. (ed.); Springer-Verlag, New York, 
1981, pp. 219-23S-:- ~ 
43. Porter, A. D.; Godding, E. W. Brit. J. Dermatol., 1945, 2]__, 197-
200. Chem. Abstr., 1947, 41, 2466. 
44. Saffioti, U.; Montesano, R.; Sallakumar, A. R.; Borg, S. A. 
Cancer, 1967, 20, 857-864. 
45. Sadano, C. S. "Vitamins: Synthesis, Production and Use", Noyes 
Data Corp., Park Ridge, N. J.; 1978, pp. 2-33. 
46. Sporn, M. B.; Dunlop, N. M.; Newton, D. L.; Henderson, W. R. 
Nature, !21.§, 263, 110-113. 
47. Sporn, M. B.; Dunlop, N. M.; Newton, D. L.; Smith, J.M. 
Federation Proc., 1976, 12_, 1332-1338. 
48. Stepp, W. Biochem. Z., 1909, ~' 452-460. Chem. Abstr., 1910, 
485. 
49. Stepp, W. Z. Biol., ~' 'j]_, 135-171. Chem. Abstr., 1912, £., 
103. 
50. Van Scott, E. J.; Yu, R. J. U.S. Patent 3,932,665; January 13, 
1976. 
51. Wald, G. J. Gen. Physiol., 1935, 18, 905-915. 
52. Wald, G. J. Gen. Physiol., !.2]2, 12_, 351-371. 
53. Welch, S. C.; Gruber, J.M. J. Med. Chem., :!222• 22, 1532-1534. 
193 
54. Welch, S. C.; Gruber, J.M.; Rao, A. S. C. P. J. Med. Chem., 1982, 
25, 81-84. 
55. Wolbach, S. B.; Howe, P. R. J. Exp. Med., 1925, 42, 753-778. 
56. Wolbach, S. B.; Maddock, C. L. Proc. Soc. Exp. Biol. Med., 1221, 
!_]_, 825-829. 
57. Yu, R. J.; Van Scott, E. J. U.S. Patent 3,932,665; January 13, 
1976. 
VITA 
Kristy Marie Waugh 
Candidate for the Degree of 
Doctor of Philosophy 
Thesis: Part I. SYNTHESES AND NMR ANALYSES OF SELECTED 
w-(2-ANTHRYL)SUBSTITUTED FATTY ESTERS. 
Part II. SYNTHESES AND CHARACTERIZATIONS OF SELECTED 
HETEROAROTINOIDS 
Major Field: Chemistry 
Biographical: 
Personal Data: Born in Lawton, Oklahoma on June 28, 1956, the 
daughter of Mr. and Mrs. Bud Waugh. 
Education: Graduated from Eisenhower High School, Lawton, Okla-
homa, in May, 1974; received Bachelor of Science degree in 
Chemistry from Cameron University, Lawton, Oklahoma in May, 
1978; completed requirements for the Doctor of Philosophy 
depree at Oklahoma State University in July, 1983. 
Professional Experience: Undergraduate research assistant, 
Oklahoma State University, summer of 1977; Chemist, Halli-
burton Services, October, 1978 to August, 1979; graduate 
teaching assistant, Oklahoma State University, 1979-1983. 
